[PAD]
[UNK]
[CLS]
[SEP]
[MASK]
.
0
1
2
3
4
5
6
7
8
9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
a
b
c
d
e
f
g
h
i
j
k
l
m
n
o
p
q
r
s
t
u
v
w
x
y
z
##o
##e
##n
##z
##y
##m
##B
##2
##4
##8
##9
##i
##p
##h
##s
##a
##t
##x
##g
##r
##k
##c
##l
##u
##C
##P
##d
##v
##1
##T
##w
##Y
##E
##5
##0
##A
##R
##G
##F
##f
##N
##X
##b
##S
##O
##U
##3
##K
##M
##D
##I
##V
##6
##L
##H
##J
##7
##Z
##q
##W
##j
##Q
##in
##at
##on
##he
in
##ed
an
##it
##en
##es
##or
##as
##ro
of
the
##ti
and
##er
##an
##al
##ic
##ion
##ec
##el
##ib
##re
##id
##ol
##is
##ar
##et
ac
##ine
##hib
##hibit
##ase
inhibit
##uc
##os
##ent
##yl
##ul
##tiv
##ation
##ing
th
##ep
##am
to
##ac
##ot
##ly
pro
by
##ated
##ph
##res
activ
##oc
##st
##duc
ex
##om
##ig
inhibitor
##ur
##ith
##le
##tor
that
##ress
##tion
al
##ate
##ts
##ell
with
##um
##ity
##ff
##ut
##press
as
##ter
con
##ran
##ag
##iv
##ow
##il
is
induc
su
##ox
##te
##if
##yd
##ide
cell
##eptor
##op
for
##ist
##ant
inc
##rans
##im
##ev
##reas
##us
##od
##ip
##pression
rec
was
##eth
##ffec
The
res
##ab
ph
cy
##em
en
##un
##ign
##th
activity
##og
##ydro
expression
acid
or
##rom
on
cells
sign
effec
receptor
##hen
st
##ir
##tic
##the
trans
##osph
induced
ad
ch
##ere
##ym
##ific
##yn
##tein
##ra
##one
##cl
##ment
##min
##ies
##ectiv
##tag
mic
##yp
##ay
##reat
##reased
In
##ug
##ud
##inase
##tagon
antagon
phosph
protein
at
wh
were
inhibition
com
pot
##iz
re
##end
##se
##av
ag
syn
##yr
dep
dec
gl
ox
##reatment
##ical
##ain
##ich
##pha
##evel
kinase
##NA
##amine
inhibited
red
##gul
##anc
##tr
##ers
sel
##ia
which
comp
##endent
micro
ap
bl
##zym
##gen
reduc
##ath
be
##est
##ethyl
sub
##ines
##ad
alpha
##ely
sp
##ial
##own
##ind
##enc
selectiv
##ap
##ive
##eta
dependent
signific
di
##hydro
car
inv
gen
##ose
sh
level
inhibitors
significant
##oun
produc
cycl
##ock
are
##OX
##uman
treatment
but
im
##so
##ates
increased
##ch
##por
##ren
human
10
##iated
##oth
##rol
effects
##henyl
##ann
sup
de
##sis
##str
##ther
hydro
med
rat
##rease
stud
##YP
CYP
amin
##ov
resp
ind
##ular
enzym
also
cat
from
##ous
fac
ne
##lu
signal
##MP
resul
##ted
##ration
block
##ens
##oxy
cl
met
##ore
rel
not
selective
##her
ar
cyt
factor
##enti
microM
COX
##amm
antagonist
beta
pre
##fer
activation
##ism
##ents
##ound
##igh
inhibitory
##GF
##oryl
##pro
##ast
PD
anti
##ator
##ugh
regul
gro
##idine
levels
##ob
##arg
agon
phosphoryl
IL
##AT
##RNA
##OS
##qu
ser
##az
##ating
cont
pl
we
##aly
##ved
spec
conc
tr
both
co
hydrox
gluc
show
##tig
##all
dr
##tim
##ogen
##ype
##ized
##ium
adren
effect
synthe
##ure
##inding
mod
##olines
increase
mRNA
path
##och
mediated
##opt
##way
##ally
##00
##entration
significantly
acet
am
##ero
qu
concentration
HT
NF
##amide
##trac
ass
chann
channel
##abol
pathway
##and
signaling
EP
##ists
apopt
##genase
down
##terase
decreased
enzyme
##tid
##ole
##ied
##onic
PDE
dis
up
##ucle
##timul
##ond
results
drug
##ases
cataly
its
##50
inhibits
##ke
##ech
##oceptor
specific
##hyd
suppress
showed
stimul
methyl
phosphorylation
adrenoceptor
##itive
CA
pyr
##ue
##rough
through
##ence
carb
nucle
sul
targ
acetyl
target
PG
inf
##ros
potent
metabol
agonist
le
##tive
invol
ab
##ition
this
amino
##ta
##othe
sug
##gest
##ess
##umor
par
##pl
##ues
un
dose
hav
##lyc
meth
##enz
##uch
##of
##cr
##itro
##osis
##amin
##port
binding
kg
receptors
synth
have
form
suggest
pr
##orm
##ys
##ost
glut
rev
##ities
their
us
via
##ible
reduced
ca
tumor
##ex
##olinesterase
type
##atic
##ons
##eriv
##olog
MA
inter
##ary
##ency
indic
synthase
mon
##yt
##eptid
##ransfer
production
high
has
##hanc
##TP
than
enhanc
may
such
tet
##arb
end
oxid
cyclo
CYP2
##wth
deriv
##estig
##osin
antagonists
investig
apoptosis
PGE
GS
found
growth
fol
##ulin
again
##ect
activities
quin
pos
phen
##yros
##mine
##per
all
potenti
can
whe
##oid
substr
##cholinesterase
study
respectiv
nuclear
against
dip
ev
phenyl
well
##lamm
##urther
50
II
##cin
##up
##arm
respectively
hyp
low
mit
##atory
cor
cur
pres
##ric
##NOS
##regul
rats
IC
VE
VEGF
dem
iNOS
tyros
these
##lud
action
includ
tetra
Ca
##lial
##ard
AC
##ease
##atin
tetrahydro
##uro
##RK
##asp
prev
##der
##ative
##olec
mice
##echan
EC
sec
##lor
##ility
studies
##ransferase
ob
##dition
##echanism
ERK
TC
##ax
anal
##able
##oxygenase
inflamm
mut
##1A
been
NO
mechanism
##DD
##onstr
##anine
acc
gene
molec
##ong
ins
potency
##ction
synthesis
tyrosine
TCDD
analog
We
##inical
##aline
series
secre
14
des
mg
##ever
##aspase
el
pat
int
inhibiting
##rome
demonstr
bi
##af
##uk
##reated
##unction
cyclin
hydroxy
suppressed
17
nov
##asc
##etin
##ently
##oxyl
AB
Th
lip
##bin
##MT
genes
##over
##erox
sulf
ATP
##erg
##athion
##luor
investigated
##ked
##olic
##uld
##act
##ious
##pa
##hE
glyc
rep
##AR
##ellular
##ytes
15
caspase
##ri
##rin
##ilar
arg
novel
Al
These
vitro
##osyl
##uron
##rain
pati
11
##ub
##amate
##activ
##ste
##age
control
##ochrome
##ten
##idin
##oline
##ach
##tracellular
channels
##hydr
curr
5H
GA
est
##olol
##iss
##agl
only
##ochond
##crip
##ochondr
Ph
PI
##DC
##ance
##ological
##armac
patients
bas
non
treated
##hem
prost
transcrip
regulation
DNA
Na
val
##ile
##transferase
##LT
##enin
##ang
prol
acetylcholinesterase
##ting
##atur
including
nit
acids
##irst
clinical
PGE2
mitochondr
sm
##rine
##uct
##imilar
str
compar
reduction
##regulation
transcription
sens
##oA
##ET
##idyl
##ffer
induction
compound
##porter
concentrations
assoc
cal
hist
##our
##otic
##aph
##3A
##emb
catalyz
involved
af
det
kn
my
other
tiss
##ycl
##uated
##ativ
##ified
oxide
##ight
group
whereas
PP
per
tim
##ak
##NF
##DA
regulated
model
inflammatory
secretion
##ual
atten
molecul
20
col
hep
me
pol
##oph
##ily
##ver
##65
transporter
fold
nitric
cle
ep
eth
##tase
##vers
##1B
##ane
activated
##ome
##rad
proteins
##ization
related
cytochrome
MAO
diphenyl
associated
after
12
AMP
##ok
##par
aden
admin
revers
caus
endothe
##tin
##rap
##out
##R2
##ene
##ild
decrease
dihydro
100
plas
glucuron
stimulated
mar
##ood
##unit
subunit
could
GAB
Further
PK
function
most
##low
##CK
##ected
addition
GABA
##pos
##01
##OR
##DH
##asone
##ations
CYP3A
using
BP
brain
did
##ser
##LA
##ins
prom
microg
eff
similar
##roph
##ameth
##ocytes
##owever
##opro
##reases
pharmac
appro
##amma
substrate
##ascular
nor
##ifer
enzymes
drugs
##take
eval
##ree
##osit
chlor
release
involv
potential
##aphth
13
More
##erol
##yc
oxy
##appa
poss
demonstrated
Moreover
ele
naphth
##CT
##ties
##ides
gener
##tigmine
EP1
repor
##atives
endothelial
##sized
##38
differ
##arboxyl
deter
TNF
UG
affec
mT
mann
##eal
##RP
##IP
##inc
##inine
##ulation
##amic
oxidase
AChE
mTOR
BA
##54
##ither
##esis
##ici
express
##lex
phosphate
##ouse
glucose
cleav
Ak
gamma
##B2
##CA
##benz
anhydr
##ass
##ffin
##GFR
derivatives
known
Akt
anhydrase
affin
it
liv
mouse
p2
##stem
##raz
##eptidase
lower
##atinib
manner
NH
Ras
bet
chem
hig
ket
kappa
mul
##oxic
combin
cytos
carbonic
cyclooxygenase
accum
values
##amethasone
p65
##nt
##wo
##onse
##arin
cons
phosphat
blood
impro
response
metall
used
higher
P4
cA
had
##oic
##treatment
##stit
##odies
effective
##evelop
mono
presence
insulin
##agland
compared
24
AM
CoA
Wnt
develop
natur
##ma
##more
##MA
active
contr
transl
Inhibit
reductase
blocked
synthesized
metabolism
prim
lipid
arginine
Furthermore
promot
30
DE
li
no
therap
##acin
##action
contrac
##odium
##ably
##ability
while
complex
##zyme
pyridine
GSK
16
dual
either
po
role
##ough
##ne
##zol
##ail
##xim
##cle
##EK
##inosit
##onical
##enal
acyl
expos
catenin
neuro
##ogenesis
canonical
struct
natural
AK
arom
benz
canc
oste
test
two
##ES
##enzyme
##ostigmine
##ocation
ext
##istration
one
transport
derived
##activation
mitochondrial
b5
first
var
##gi
##last
##hed
##orph
##ibro
##olated
thi
proper
##anth
##ogl
produced
respons
under
enhanced
prolifer
P450
dos
more
perox
sodium
wild
##TA
##ward
##ites
##erm
##ulf
new
##okine
Me
SR
id
memb
ste
##nit
##ystem
##di
##1a
##bit
angi
##ether
##amp
isolated
##ement
compet
import
deg
medi
assay
uptake
prevent
sensitive
multi
translocation
DEX
To
##fen
##SA
##ite
##ometh
transf
chang
##ynthe
##sequ
##entif
indicated
PI3
caused
##oprotein
accumulation
cAMP
contraction
Hep
RA
er
fl
p38
system
##ef
##PP
##G2
##erul
##elet
prot
##ipine
substrates
elev
affinity
PI3K
HepG2
PA
ir
rap
##rel
##MS
##inal
##erc
##idaz
##oles
toward
dex
dehydro
60
dop
great
less
vascular
yl
##CL
##ata
##onium
##eno
##active
##iven
oral
shown
imm
downregulation
leuk
prostagland
PPAR
liver
important
Bcl
renal
##DP
##ately
##roc
thym
alanine
resist
order
##aining
resulted
##crib
formation
obser
histamine
attenuated
Inhibition
further
viv
##eu
##gether
##CC
##53
##hep
##istic
##ylase
together
##irect
products
reveal
CYP2D
quinolines
tissue
UGT
vivo
1A
Bax
NET
gall
mus
ov
##eic
##ycin
##93
##sp
##CR
##12
##oma
convers
##rane
cardi
glutathion
present
mutant
plasma
like
exposure
cancer
properties
##omethacin
dopamine
25
CS
E2
TS
finding
hC
##ER
intracellular
##acter
##osphate
CYP1A
catalytic
follow
Ca2
##ukin
administration
monoamine
primary
doses
##ynthesis
findings
Ch
Glu
Pre
dur
data
fr
##ear
##2A
##T1
##SG
##enib
##ester
##ished
##ylamide
exhibit
ald
serine
apoptotic
disease
##afenib
##idylinosit
phosphatidylinosit
identif
observed
##eutic
conversion
phosphatidylinositol
Cyp
Gl
ast
mal
##lag
##10
##IF
##rog
##ace
examin
##umar
##oxib
##opeptidase
suppression
cyclohep
CYP2B
molecule
prevented
cyclohepta
BR
bis
##ein
##let
##RF
##NK
##OP
##atase
##orafenib
##rop
##ert
##osine
##leukin
phosphodies
##obut
methoxy
interleukin
describ
small
AMPK
NHE
competitive
27
PL
##zil
##PS
##ortic
##tis
##ionine
##idase
##ult
prov
extracellular
##tered
induce
decarboxyl
##ade
lead
parti
##oids
PhIP
hepatic
marked
different
revealed
cap
##ND
##itiv
##rosis
##ols
##oside
three
##amily
tox
##ective
aminopeptidase
##eptide
myosin
chloro
expressed
changes
glutathione
CYP2B6
ALA
hem
tol
when
##oenzyme
##ehyd
##mit
##CP
##16
##SI
##icl
activator
##reasing
rati
containing
coumar
querc
displ
ability
caff
MAP
whether
approxim
determin
##nitine
dehydrogenase
examined
decarboxylase
quercetin
approximately
LPS
pur
se
##ril
##ures
##inases
##ibut
##olin
##aracter
prob
##ocy
exc
without
inducible
increases
selectively
carcin
class
agonists
##ogenous
pyrid
GSH
phenolic
previous
DH
PT
SH
TL
kur
nec
##oyl
##ix
##100
##RO
##ON
##D1
##VA
##esulf
##olar
##etr
##ifluor
##imethyl
phys
##renaline
EP2
VEGFR
analogues
into
##ergic
smo
oxygen
tested
extent
##oleste
caffeic
TLR
01
Ac
AA
AS
HS
MMP
MSG
NM
fel
panc
sc
##99
##ie
##we
##but
##MF
##HMF
##onin
##icin
acin
##ages
alpha2
indicate
phenol
This
5HHMF
times
kappaB
proliferation
##olesterol
3H
300
Ad
bu
ferul
however
nM
sal
syr
##ramine
##co
##vin
##fibro
##IR
##itamin
##ingic
##imin
chain
pretreatment
suggested
analogue
ellag
hydroxybenz
compounds
catalyzed
hepat
ethyl
evalu
metalloenzyme
therapeutic
gallic
##ehyde
coumaric
##esulfon
ferulic
syringic
ellagic
hydroxybenzoic
AR
HVA
MB
lin
nitro
norm
##89
##tan
##uv
##roid
##alanine
##acyl
prote
##umin
##odipine
##emfibro
##though
diab
ERK1
molecules
reported
improved
##stitu
rapid
immun
phosphodiesterase
NMDA
##emfibrozil
42
CB
JNK
MDA
Myc
Nr
rab
use
vitamin
##tal
##57
##inor
##inosyl
inj
##rogen
##anol
##alpha
##ylcholinesterase
##epine
##amines
##otoxic
prop
##omp
aspar
isof
recom
##emic
##av1
trinor
pathways
IC50
currents
reversible
combination
degrad
CYP1A1
Nrf
##inosylvin
CP
CD
EGFR
However
TH
TOP
due
long
mel
op
our
##25
##iol
##ses
##sul
##rost
##omethyl
##tics
character
##izes
selectivity
##ount
arach
serum
stimulation
glutamate
positive
phenylalanine
bios
tissues
time
meas
glucuronide
involvement
betwe
##zolamide
various
necrosis
TOP2
arachid
between
fluor
gal
kinases
lig
min
p53
sur
sero
##mon
##26
##tonin
##C1
##form
##ature
##olip
##ylate
##ull
prof
##ocl
concl
cholesterol
antagonized
phospho
targets
tetrahydrof
current
calc
ethanol
reversed
evaluated
structure
aromatic
transfected
prostaglandin
markedly
ratio
TLR4
aspart
isoform
serotonin
AP
DA
LT
Our
SC
family
hex
ma
##mg
##pyr
##br
##OD
##jor
##icac
##ream
##istered
##acch
##imit
##indac
dependently
content
carboxyl
highly
hypothe
glycine
##idylate
catalyzes
adenosine
cleavage
p21
mediates
dexamethasone
thymidylate
CYP2D6
pancreat
Nrf2
ligand
major
55
HIF
IF
MEK
NA
NR2
direct
py
##24
##XM
##64
##atelet
##hes
analy
##itaz
##orpor
##idate
##old
##arly
##stream
##omer
##uran
alk
##ired
transfer
decreases
species
trial
downstream
upregulation
adrenoceptors
administered
subunits
efficac
##sequently
toxic
MAPK
purified
pancreatic
IFN
##itazone
21
D1
First
GW
HO
MD
OAT
PS
SP
bec
do
equ
gu
led
limit
renin
sl
som
ter
##etic
##ian
##led
##Cl
##EC
##bo
##ber
##37
##74
##ones
##asal
##astr
##asatinib
##ucos
##phrine
activates
phase
##emia
state
##ymethyl
reactive
##yrid
studied
place
hydroxylase
modul
amine
potentiated
arginase
development
membrane
PTE
normal
##otoxicity
isoforms
OATP
placebo
1B
Ex
cer
dam
ion
ol
##met
##40
##ple
##ve
##13
##AK
##XR
##eng
##ank
##ider
##otens
activating
##ocortic
##ured
induces
inducer
##yphenyl
##ained
imatinib
superox
##ential
PDGFR
play
trifluor
glucocortic
##00W
targeted
##armaline
1400W
demonstrate
##binant
mitochondria
##yclic
##aken
naphthylamide
##oglob
muscle
during
Cyp1a
degradation
efficacy
slight
superoxide
199
AL
CX
Com
Rh
SU
Taken
gastr
harmaline
mo
pH
rate
rank
##nith
##are
##ce
##ct
##cine
##GRO
##NMT
##UND
inactivation
##ased
##aryl
##ependent
##amsul
##ocal
##iline
enc
adip
microm
##adrenaline
##etazolamide
impa
def
HT2
assess
PDE3
prec
##arbit
ABL
attenu
##CKGRO
possib
BACKGRO
##razosin
angiotens
resistance
UGT1A
##itivity
linked
##ompan
aspartate
slightly
gastric
##nithine
##amsulosin
BACKGROUND
angiotensin
1D
354
Bim
BMS
cult
dist
mamm
nic
##oin
##mod
##iro
##poc
##ronic
##k1
##FC
##atri
##ors
##ection
##ise
##amides
top
##istent
##usion
cyst
##yrylcholinesterase
butyrylcholinesterase
suppressing
abol
##plic
suggesting
interaction
enhances
##ectin
cortis
Thus
ester
BPs
possess
contribut
##anthine
described
##uvate
calcium
HDC
LOX
One
Rec
brom
del
lines
mim
pren
##yth
##k2
##F1
##atal
##enine
##ermine
##alk
actin
##oster
##tively
##ingly
##otri
##lyz
##phosphate
##letion
conj
constitu
##oxin
##henol
stress
Ind
##ize
##estinal
subt
spermine
independent
least
part
parathion
##ology
accompan
ATPase
##steine
models
mark
noradrenaline
consider
contrast
flav
followed
GluR
Glc
leading
biosynthesis
OATP1B
Compar
prenyl
accompanied
05
3A
An
A2
Ah
CH
Dex
DXM
LY
Nav1
PU
Rsp
gemfibrozil
kus
mac
morph
pip
ra
##mic
##BP
##48
##rb
##lin
##las
##IV
##inic
##onoids
##ithe
##ord
##ione
acetazolamide
##omal
##ophen
##abine
##thi
##romb
##erex
Inter
carnitine
index
phosphorylated
platelet
trig
##echin
carbon
metabolites
correl
ACS
molecular
##rinone
based
epithe
adenosyl
determine
cytosolic
AKT
RAF
overex
kurarin
rabbit
recombinant
CDK
encod
##modulin
Dexamethasone
Rspo
kushenol
macroph
43
Bu
BCR
DMT
LS
NRF
ROS
SB2
Up
WA
cG
em
early
ib
lev
mur
mucos
peptide
some
vol
##ych
##mor
##solic
##sych
##rsolic
##ChE
##AS
##K1
##inib
##orb
act
##acrine
##ster
alco
conver
agent
##estingly
cyclic
arter
##quin
metabolized
##amino
PGE1
##everal
PKC
cleaved
##CA1
thieno
MeO
greater
hCES
partial
previously
felodipine
##572
hypothesis
pyran
mammal
Interestingly
NRF2
cGMP
ibu
murine
mucosa
alcoh
Both
Cr
CR
Cys
HEK
MT
RS
SG
don
dom
ect
hip
nasal
oc
tem
##825
##lav
##EP
##for
##39
there
##erp
##ants
##ecoxib
##iderm
##etine
##ots
##otransferase
##ochem
alter
alone
##uted
##tem
app
diaryl
deoxy
aminotransferase
indomethacin
blocking
regulating
##oblast
pyruvate
methan
glutamine
quinoline
mutation
strong
calmodulin
norepine
##icient
better
AKR
##rocytes
BRL
determined
acinar
proteas
trials
354825
##pocamp
cystathion
cortisol
CrAT
hippocamp
##idermal
norepinephrine
40
BD
DAT
DMA
FU
GR
H1
HN
Here
Kir
NS
Rac
day
flu
fail
kid
line
mem
sorafenib
ursolic
##ould
##80
##gress
##cumin
##ling
##CF
##beta
##S2
##ater
##itis
##itagl
##enesulfon
##revers
##idence
##omes
##oxid
##iphenyl
##iptin
##ung
##irac
antagonism
atr
support
neg
##OSE
hydroxymethyl
PDE4
catalyses
oxidative
##regulated
inflammation
ABCA1
Although
currently
transcriptional
myel
poly
dihydropyr
##RPOSE
expressing
developed
aromatase
responsible
angiogenesis
irrevers
cardiac
CSE
Pretreatment
##obutyr
smooth
hepatocytes
##osterone
##otriene
Indomethacin
AhR
PURPOSE
##rbB2
BuChE
##formin
##ochemical
cystathionine
HNE
Kir6
kidne
##itagliptin
irreversible
1c
23
CCl
DB
DNMT
ED
Gly
Hb
ML
MAT
On
SER
av
cd
cin
fos
furo
het
lys
lung
man
main
pA
prazosin
retin
tacrine
wor
##top
##tus
##ks
##kinase
##ution
##C2
##A4
##ben
antic
##rex
##remor
##ison
##isons
those
##otrop
##stone
transi
chronic
##mentation
whole
requ
##ady
treatments
neur
blockers
##prostone
antip
##ogenic
sulprostone
abs
partic
methionine
indicating
##perim
##ergistic
mean
polym
transporters
##aneous
diphenylthi
oxygenase
naphthyrid
generation
cytosol
consistent
improv
GSK3
poisons
responses
multiple
##DPH
##esterases
exhibited
probably
tetrahydrofuro
NADPH
##oglobin
epithelial
pyrano
ecto
MLCK
cdk2
diphenylthieno
naphthyridines
900
Con
DPP
ME
Nex
Pl
PAR
Pinosylvin
az
cis
lum
mes
num
pal
slow
##oz
##oac
##88
##kast
##CO
##viv
##b1
##IT
##onidin
ant
##til
##elarg
##etes
thromb
activate
##stero
expl
within
##ranlu
##agiline
##oxane
increasing
##imer
##abin
##thal
add
##minal
antagonizes
##annabin
##lux
blocker
##ensity
##obarbit
##tidine
suppresses
sulindac
methox
##ofen
design
clinically
functional
##ince
##razole
structur
steroid
##idazol
hCOX
SHMT
evaluation
arachidonic
NR2B
toxicity
terminal
mammalian
negative
PARP
number
##elargonidin
thromboxane
##steroid
##ranlukast
##obarbital
39
35
BT
BM
BLT
Hydro
NOS
Pro
RNA
STA
Sorafenib
Tr
TP
VG
WI
da
dimethyl
es
full
ke
mil
pelargonidin
site
several
##oots
##max
##49
##iation
##ty
##transfer
##g1
##glyc
##car
##litazone
##down
##flav
##MC
##J2
##inin
##esc
##ory
##ora
##rox
##alc
##isinic
##ylhydro
##ylamino
##epress
##other
##oterol
##otremor
##urs
##oxal
##tex
incorpor
##imal
##imidine
There
chalc
##ayed
oxotremor
##iaz
##iazol
being
##chlor
prefer
antioxid
##azide
contents
amben
HT1
##echol
pred
##eptidyl
mitogen
curcumin
ABP
ABCC
##overy
pharmacological
affect
##stituted
neurot
b5R
identified
##ocyte
##ieties
1997
moieties
possibly
abolished
macrophage
artery
CysLT
##temisinic
##iracoxib
avail
STA2
VGCC
daily
##transferases
oxotremorine
##chloride
ambenonium
001
18
1alpha
Am
At
AI
BH
Cp
Mg
MCP
ST
Synthesis
S100
SIR
density
ed
fib
free
here
horm
mG
mM
put
rem
sing
tamsulosin
vas
##oechin
##methyl
##tom
##rug
##cannabin
##vious
##R1
##GE
##NP
##35
##inyl
##inant
##atrol
##onal
##ided
##ety
##yloid
##ulature
##eption
experim
##omycin
conf
##oxetine
##ody
cyan
ornithine
effectively
transition
adhes
##avar
decreasing
spl
sperm
implic
resulting
blockade
relative
cytotoxicity
amount
HT1A
##onding
##ostatin
actions
obes
##asculature
colonic
##veratrol
dihydrochloride
##016
pharmacokine
##IP1
BAY
combined
therapy
contractions
greatest
CSF
following
##iclofen
displac
sequ
##olinergic
physostigmine
THF
GW572
limiting
olig
assessed
conjug
##quinone
kidney
##otropic
9006
Nexavar
WIN
CpG
S100A4
SIRT1
mGlu
##oechinulin
##cannabinol
adhesion
spermidine
##iclofenac
GW572016
07
AT
Cl
CO
DM
F3
Fluor
Iress
OB
RES
Sub
ZD1
fibro
gramine
hom
kine
lact
rac
##eti
##mol
##839
##iod
##ption
##aus
##gl
##ger
##gan
##ganine
##dehyde
##vul
##18
##ECT
##bamate
##JECT
##oned
##onvul
##herol
init
##itabine
##enic
##ecific
##ark
##arone
##aridin
##ational
##aminase
##amster
##acil
##lyrin
extrac
##illyrin
##oxype
##opath
##opherol
##ipher
##ethionine
cysteine
organ
##iren
transaminase
synergistic
##ically
complet
produce
catal
neostigmine
artemisinic
cytokine
amyloid
disc
stimulate
stimulating
nucleus
leuc
##otherap
desoxype
esters
Pharmac
prostatic
histopath
##ouracil
knock
groups
perform
peripher
##ophosphate
glucuronides
efflux
##rophonium
##iciency
keto
##oxicam
metalloprotein
promoter
##anthamine
peroxide
SRC
eryth
resistant
##ERG
aldehyde
asth
hemoglobin
pyridostigmine
##butamide
Addition
diabetes
meloxicam
galanthamine
surviv
Rho
impair
constitutive
subtype
##sychotic
strongly
hetero
antipsychotic
lumiracoxib
key
chalcone
edrophonium
displaced
Iressa
OBJECT
ZD1839
##onvuls
desoxypeganine
OBJECTIV
510
AE
AH
Bl
BI
CK
CON
CIP1
Dk
En
E1
FLT
GC
KA
MET
NC
Nox
Sp
St
SOD
Tom
Us
UDP
dys
fed
four
iod
jun
kain
ly
matri
ner
pIR
rout
sym
sites
would
##mia
##43
##p2
##aine
##rd
##ram
##riz
##kelet
##carb
##C9
##ErbB2
##5ErbB2
##blast
##ULT
##USI
##ale
##alol
##ication
##elta
##elective
##arc
acut
acting
##ame
##amycin
total
##ocarboxyl
##ocaine
##ometr
along
##ophenyl
resc
step
transm
##ymidine
##tage
##ude
##udex
##izing
synap
depletion
##inese
##ovascular
neoechinulin
signalling
arres
cytok
##profen
antigen
##AT3
downregulated
PDE5
methyltransferase
endogenous
GST
evidence
cortex
elimin
intestinal
sulfate
Also
polyp
involves
##yces
affected
affecting
CoAs
vari
steady
elevation
##CLUSI
leukotriene
Chinese
partially
diabetic
soman
GluR5
WAF1
ibuprofen
alcohol
neurons
palmit
398
antioxidant
STAT3
pharmacokinetics
RESULT
##etiriz
histopathological
51089
Block
CONCLUSI
FLT3
METH
Tomudex
lyase
matrix
cytokines
RESULTS
##etirizine
CONCLUSION
75
As
A1
CE
Fel
It
KIT
ON
Vmax
WK
ba
bat
dox
dasatinib
go
given
hand
over
peptidase
roots
sour
vin
vasculature
##ew
##eed
##29
##ior
##xolol
##ven
##11
##T2
##fot
##D2
##DE
##IL
anis
androgen
##erse
##icylate
##ibenz
##isetin
##ental
proc
##phide
##phosph
condition
##ilam
##oper
incub
##imide
recent
resveratrol
phthal
##ogn
stably
##ification
common
reIL
depend
glicl
##icalin
selectin
compon
reduces
substituted
product
hydrolyz
aminob
antib
##ators
hydroxyl
adrenaline
abrog
##ofin
##ofecoxib
enhancing
hypert
mechanisms
analogs
glycoprotein
##uble
estrad
value
calp
##embrane
##ycline
colitis
functionally
p27
ketone
peroxidase
elevated
prostaglandins
cardiovascular
identify
male
displayed
AACO
bufot
salicylate
##acylglyc
profil
profile
conclusion
##242
##uranofin
transferase
ALD
SUR2
UGT1A6
CHO
Upon
occ
polyamine
HbA
work
anticonvuls
transient
polymer
milrinone
##ause
Using
kainate
transmembrane
ONO
WKY
baicalin
source
##phosphon
gliclazide
aminobiphenyl
estradiol
bufotenine
##acylglycerol
anticonvulsant
1R
Ag
Ab
Cyt
DG
DL
Er
Fd
Given
HE
HCT
LDH
Phen
Sacch
Treatment
auranofin
bene
cig
coun
cogn
dism
each
hear
men
myr
might
mix
ng
pent
rang
sol
##B1
##iel
##hip
##arom
##ahydro
##tte
##tamine
##xanthine
##rip
##lia
##17
##5K
##OH
##Urd
##D4
##70
##enocytes
##orub
they
##anser
##idation
##isia
though
progress
##resp
##lev
alb
##ilol
##evisia
##abl
##irm
reg
reactivation
##NAc
subst
##ialdehyde
##indole
humans
aminobutyr
enzymatic
result
blocks
##ensitive
##prop
##astro
##vedilol
tri
mRNAs
##ondialdehyde
CAR
acetylch
influ
##amination
interact
oxidized
allerg
hyper
include
##ardipine
insensitive
Thd
116
establ
sensitivity
epidermal
plasmin
##ationship
CYP3A4
BPB
##LA2
element
##CT2
lowering
phosphatase
acyltransferase
GluN
duration
malondialdehyde
NHE3
PLZ
smoke
Acet
evaluate
##olipase
LTD4
hexahydro
##bry
carboxylesterases
analysis
Firstly
does
cerevisia
Cyp1a1
##arette
nicardipine
topo
contributes
##alkyl
GlcNAc
OATP1B3
embry
voltage
BDZ
memory
##CF3
dihydropyridine
confirm
splenocytes
catalase
heteroc
NCX
route
calpain
AACOCF3
DGAT
FdUrd
Saccharom
benef
cigarette
dismut
myrist
##ield
##orubicin
##anserin
aminobutyric
cerevisiae
Saccharomyces
2A
Based
Cat
D2
Di
Ep
Gal
GDC
IR
Kit
PEP
QT
Sr
Ser
U01
VI
aim
cod
dyn
diclofenac
fem
heal
kD
los
max
now
p50
rad
rofecoxib
si
tB
tub
yield
##methionine
##293
##iological
##pip
##pren
##hav
##aemic
##ral
##rup
##carin
##copherol
##li
##line
##linical
##depress
##vir
##15
##MG
##MO
##Ds
##66
##int
inactiv
##oride
##asis
##anti
##icof
##elone
##olys
##aride
thus
##eph
tocopherol
##ilit
##iloride
##opyr
##oplas
##opolys
recently
cycle
orth
orally
reaction
deplet
oxim
shor
facilit
neuron
antidepress
plus
trimethyl
driven
synthetase
formate
endometr
oxidation
position
III
corresp
lipopolys
Ald
basal
proline
PPT
colon
##insen
AM40
promotes
pool
SRE
elevates
rapamycin
dext
muscarin
frag
astrocytes
heme
tolbutamide
excit
pyridoxal
SHR
physiological
Activ
ASCT2
MBD
rapidly
CBS
measured
##accharide
MDMA
guan
trifluoromethyl
glucocorticoids
CXCL
mimic
morpholin
adenosylmethionine
SB2242
appear
CCl4
DBS
particular
added
incorporating
availability
lactate
leucine
palmitoyl
acetylcholine
established
heterocyclic
dismutase
PEPT2
Src
U0126
VIG
siRNA
##icofelone
neuronal
corresponding
lipopolysaccharide
muscarinic
SB224289
00
64
A54
BCL
CG
Dasatinib
Delta
Fc
HFC
HERG
Km
KC
MP
P2
PSA
PXR
Similar
Soph
VP
au
breas
body
cr
case
dich
ether
fav
good
light
mL
mild
midazol
nal
out
pyl
post
pinosylvin
pranlukast
ure
##oy
##eased
##yan
##matic
##aff
##tained
##tindole
##ges
##red
##kinin
##uw
##Ps
##1b1
##T3
##ft
##NT1
##ats
##atostatin
another
animal
##oraph
##alen
##icit
##ects
##ibution
##idone
##olate
##isper
acr
acts
##epr
##amyl
##actic
##rescine
##oclast
##duction
##urn
##ury
##tere
##terin
isobut
##opterin
##imidaz
##imoz
##ipramine
##abel
##thy
##iring
##osphoryl
##mino
agents
depolar
##indolol
diures
diacylglycerol
##othymidine
##stract
respir
clones
relax
relationship
##que
sertindole
##azinyl
concep
coinc
hydroxyphenyl
mode
amiloride
HT3
EP3
##ross
potently
glutamyl
enhancement
dipeptidyl
obtained
elect
##eroxidase
sulforaph
##erglyc
15mg
controlled
basis
##atively
##1B1
BPA
approved
chemokine
osteoclast
thymidine
UGTs
exhibits
Cyp1b1
##roglitazone
describe
##olscine
carcinogenic
##etron
HSD1
scaff
acini
CB1
injury
##ODS
MDZ
##ECs
trifluorothymidine
Cyp1a2
deficient
attenuate
cultures
flavesc
Compared
prenylflav
piper
rauw
overexpression
CRE
##toposide
absence
mesylate
predic
putrescine
single
completely
Additionally
impairment
OBJECTIVE
Nox4
acute
synaptic
METHODS
profiles
Abstract
Cytochrome
influence
##ephrine
A549
Sophora
breast
dichlor
midazolam
pylor
##isperidone
isobutyl
##imozide
##osphorylation
diuresis
hydroxyphenylamide
sulforaphane
scaffold
flavescens
prenylflavonoids
rauwolscine
1C1
37
BV
Cd
DZ
Effec
Four
FXR
KAT
MRP
ODC
Red
Rg1
SB
Since
Top
Tri
WT
bov
bond
fat
fen
fre
gril
hamster
much
nons
nmol
pig
press
pimozide
rib
same
##ozym
##zhe
##ytic
##mb
##pol
##piro
##sential
##tases
##rylamide
##174
##TC
##TH
##AM
##function
##NT
##Ser
##DL
##itor
##oretin
##ibef
##idual
##oler
##ised
##isome
##aring
##artan
##osomal
##ings
##ocard
##uride
although
##ateg
##ividual
isozym
inducers
restor
phillyrin
stable
chall
##raf
behav
##adione
area
hydrogen
hydrocarb
indeed
neut
##ensitivity
clamp
relatively
factors
##obu
##uretic
carbamate
metabolize
left
unit
forms
interfer
investigation
quinpiro
phenylimidaz
phenylephrine
ICa
demethyl
inside
intoler
biological
biochemical
glycogen
Alzhe
##hydroretin
##uctose
myocard
meats
polyc
##radil
pharmacology
naphthalen
generate
livers
proliferator
member
fructose
PLB
##itively
toler
exception
kuraridin
felbamate
CPT
characterization
measure
arachidon
directly
##olding
somatostatin
damages
CXCR
micromol
precurs
Comparison
prenylation
##linide
kurarinol
kurarinone
CDK2
Rspo2
Rspo3
LS174
levob
HEK293
dominant
##oblastoma
DMAs
##ateral
##enesulfonamides
cinn
improves
MEF
##oacrylamide
methoxyphenyl
essential
cyanoacrylamide
##otherapy
dysfunction
##blastine
CONCLUSIONS
vinblastine
process
##ilament
hydroxylamines
HER2
counter
heart
menadione
range
##propion
hexahydrocannabinol
embryonic
kDa
oximes
antidepressant
fragmentation
conceptus
pylori
DZN
Reduc
bovine
grilled
##ibefradil
isozymes
challeng
hydrocarbons
quinpirole
phenylimidazo
Alzheimer
polycyclic
LS174T
03
212
3a
44
680
Ap
AGE
Bak
BNP
Cro
CDC
DP
EBP
G1
GMP
JAK
Licofelone
MK
Mcl
Methyl
NR
NSA
PMA
Sc
SD
SL
Sitagliptin
TR
TRP
aortic
bal
bur
cocaine
foc
home
lith
p9
pR
pCP
pindolol
tran
turn
xanthine
zap
##oked
##men
##28
##iability
##go
##rec
##rate
##ribution
##cy
##PA
##11a
##5k1
##flamm
##SS
##SO
##inflamm
intr
inosit
##ention
##erix
##ick
##eline
##elte
##rees
##arily
##entric
##ylamine
##epti
##amelte
##otin
##umption
##ranolol
##ill
##oxat
cellular
##antoin
They
##romal
stromal
##irin
transactivation
##ynur
synd
reduce
subsequently
##aprost
diet
butaprost
##chang
103
rather
clof
metformin
antimet
##obil
moder
HT1B
PDE2
PDE1
##hydantoin
targeting
former
##ostasis
monocl
##ytoin
CYP2C9
quinaz
events
50mg
tyrosinase
prevention
mutants
intact
bio
##afor
lipoxygenase
##rinast
##osylated
##osyltransferase
##activity
estrogen
baseline
prolong
comparable
##embly
catalyze
diphenylhydantoin
glucuronidation
microglia
possible
##inct
##amics
##iciently
Rasagiline
chemical
ketanserin
promote
promoting
##inositide
peroxisome
degrees
assays
##erulein
PAH
leukemia
Bcl2
ovary
leads
immunore
melan
characterized
phosphoinositide
carboxylic
##omerase
alkaline
##metric
glucocorticoid
ALDH
distribution
distinct
nicotin
flavonoids
pip5k1
correlated
overexpress
CDK4
converted
hCES2
hCES1
methanone
methanesulfon
proteasome
hippocampal
hippocampus
atria
SERT
mainly
pA2
retinoblastoma
required
Plerix
structural
Trk
AIMS
Mg2
oligomer
kinetics
knockdown
peripheral
asthma
symp
arresting
conditions
components
abrogated
BDZs
Differ
dynamics
##oplasmic
short
endometrial
AM4054
morpholinyl
Fc11a
urea
depolarization
fatty
##hydroretinol
CXCR4
processes
6809
Crocin
CDCA
NSAI
homeostasis
lithium
p95ErbB2
pRb
pCPT
zaprinast
##inflammatory
inositol
##entricular
##amelteon
antimetabol
monoclonal
Plerixafor
2B
2R
2H
200
488
69
90
ASA
Bad
Cx
CM
CAT
Cycl
CCK
CB2
Corpor
FDH
FMS
GTP
Genzyme
HU
HK
HL
MG
Not
PC
PR
Prost
PLA2
Sul
Tg
TF
TD
TZ
U50
V6
Val
aor
bic
bud
bind
cent
estr
loc
mig
pi
pem
satur
sitagliptin
typ
tyr
term
trop
tert
ver
##eg
##iothe
##iary
##pin
##phen
##aemia
##tle
##treated
##ron
##upl
##PO
##P5K
##drug
##val
##TS
##YA
##AP
##ful
##fore
##by
##3100
##D3100
##VECs
##63
##jective
##jects
##onucle
anth
##itr
##itumor
##ittle
##enol
##astigmine
##erone
##anin
##icial
##idil
##idog
##olateral
##isetron
##etrex
##inea
##ucur
##ucose
##uccin
##ulum
##otype
prodrug
##phost
##omers
##uridine
##utes
##ivastigmine
##ilib
inducing
##ify
##opa
##istin
##odil
entr
enanti
##und
##rometh
##tical
##ticulum
transgen
cholinergic
ref
reticulum
apoA
subf
subjects
##adine
##aps
carvedilol
produces
butylhydro
death
medium
##astine
regulatory
phosphorylase
phosphorylates
##azosin
##00E
NFAT
PDE6
PDE10
catalyst
sulphide
unified
methiothe
##aminophen
glut3
##ologous
monophosphate
tetr
investigate
##perature
potentiation
ACTH
bile
sulfide
glycaemic
repres
PIP5K
basolateral
##LT1
##yclam
causes
generating
report
reporter
affinities
NHOH
ketamine
cytoskelet
monooxygenase
AMD3100
benzenesulfonamides
osteoblast
extens
##oglitazone
undergo
##bitacin
assayed
multikinase
Previous
aldo
aldosterone
astrog
bisphosphate
PLP
probe
AADC
ASS
HSYA
useful
proparg
propranolol
opi
fluoro
minutes
tetrahydrofolate
IFNT
because
guinea
limited
esterified
marker
OATP1B1
trigger
encodes
encoding
RSPO
SGLT1
donor
domain
temperature
thereby
deoxyuridine
proteasomal
failure
atrial
hydroxymethyltransferase
MAT2A
Hydrogen
##echolamines
VGCCs
hormone
COMT
Fluorouracil
racemic
synergistically
metalloproteinases
AE3
iodo
Blockade
Felodipine
doxorubicin
cognate
mixed
pentobarbital
##riptan
thought
albumin
triphosphate
plasminogen
beneficial
Catecholamines
healthy
##opyrimidine
SREBP
Similarly
Top2
behavi
measurement
cinnamic
Reduced
ScCA
SDF
moderate
overexpressing
antimetabolites
488H
Cx43
CML
Corporation
HUVECs
Sulindac
TFP
TDI
V600E
aorta
bicyclam
pioglitazone
pemetrex
tyrphost
tropisetron
##idogrel
##ucurbitacin
entry
butylhydroquinone
methiothepin
PIP5K1B
cytoskeleton
astroglial
pemetrexed
tyrphostine
28
26
293
Ar
BMP
Catal
Cyan
EG
EL
Gemfibrozil
Im
ID2
MU
Nor
PF
Park
Prec
RE
Res
TX
TK
VM
When
athe
aug
ble
cil
cucurbitacin
dT
etoposide
gp
gly
gef
gastro
hG
hal
imino
mm
pul
ramelteon
side
saf
train
vir
viability
ventricular
xen
##eiv
##eoxy
##eases
##net
##zine
##zap
##zole
##BT
##42A
##901
##sc
##gn
##rone
##racyl
##cular
##lase
##lot
##lium
##ually
##1c
##NS
##ble
##ST
##Sat
##ISA
##onidine
##onaf
##onatal
##hetamine
##itical
##itinib
##orect
##anzap
##ectr
##elf
##idide
##idues
##etSat
##ucifer
##osp
##amb
##ack
exerc
exchang
##omet
##uring
##tions
altered
allev
asym
susc
##oxant
##oxone
##evant
##uscular
record
receiv
residues
expressions
once
##iramate
cholinesterase
##ministration
phospholipase
##avail
##ains
micros
##genases
beg
##ences
##april
dihydroretinol
##hydrolyz
indirect
individual
##MPDE
##ensit
clos
relevant
##entially
agonistic
##AT2
##quit
##azine
weight
modest
modulation
modification
acetate
amonaf
diseases
itself
methylxanthine
about
synthases
glutamic
caerulein
interval
indicates
monocyte
monocarboxyl
hyperglyc
mitoxant
CaMPDE
desensit
elicit
electr
##afil
##idinylamino
basilar
nonhydrolyz
colorect
clear
cause
microglial
affects
##CA2
##aglandin
poor
exposed
##ulfide
mediator
change
erlot
proton
protect
fraction
Glut
##ertain
NHE2
NHE1
provide
capable
toxin
##166
determination
carcinoma
DHE
MMP7
##iew
bupropion
analyses
alkyl
PSE
modulate
damage
olanzap
plays
SUR1
impaired
attenuates
cultured
contribute
bromide
##alkiren
markers
ACS4
##orbate
tempor
AKRs
fluoxetine
myelogenous
foscar
lysine
antitumor
explor
obese
sequential
DMBT
Subsequently
discovery
performance
survivin
nerve
CEase
batracyl
anisidide
incubation
dependence
allergy
##prenolol
##insenoside
critical
favor
naloxone
acridinylamino
HSD11B1
CREB
frequ
pressure
##eptible
syndrome
bioavail
PAHs
melanogenesis
ALDH2
697
Prostaglandin
opioid
BMP4
Catalpol
ELISA
Preclinical
gefitinib
training
##uciferase
exercise
susceptible
amonafide
mitoxantrone
nonhydrolyzable
colorectal
erlotinib
olanzapine
foscarnet
batracylin
2C
31
45
4H
47
61
737
89
Af
Ast
AND
Beta
Car
CMP
Cons
Cav1
DF
Dis
Dep
EET
FAK
HG
IK
LC
Mon
Meth
MCT
Ne
NE
NGF
PCR
S1
S6
TGF
Type
Tamsulosin
Wester
air
bre
bcl
bepr
cop
casc
cef
cibenz
difluor
etom
fast
gated
local
little
luciferase
mV
mibefradil
nap
ras
ril
roles
ses
sim
vein
wide
zinc
##nes
##zoline
##mend
##iate
##hr
##sa
##auc
##aox
##taneous
##x2
##xylamine
##rind
##kely
##ced
##corbate
##uB
##564
##fs
##fag
##buride
##VP
##atter
##onine
##onoun
##ontaneous
inactive
inotropic
##itary
##enolol
##enafil
##ornithine
##role
##erted
##ans
##eceptor
##reen
##reonine
##isk
##ylmethyl
thaps
threonine
exogenous
##igarg
##toreceptor
ascorbate
consequ
consequently
##ival
isop
##opidogrel
##isting
##imus
onc
stri
##ymeta
##ays
atenolol
##izole
oxo
oxymeta
##ersensitivity
appar
aprind
substitu
##adrox
spontaneous
cycloxygenase
cloned
clopidogrel
metast
arylhydro
##astatin
weak
tract
triazol
coupl
droned
##ogenated
adrenergic
amiod
quant
disord
disrup
upon
metabolite
paraox
formoterol
pronoun
reverse
CYP2J2
quinone
phenformin
allel
IIA
hypersensitivity
mutated
mutations
account
intro
biopterin
170
sulfon
sulfamate
sulfatase
glycosylated
GAD
prostate
##aturated
comparison
pertus
timolol
AMPA
adenine
involving
##erolimus
generated
reports
UGS
##stemizole
primarily
likely
##orphan
##TA4
transfers
##idazin
proven
excre
DHP
screen
ethylm
injected
injection
recommend
longer
##omethylornithine
conclude
DASI
GW40
becomes
double
modulators
Existing
ceramide
adipose
angiotensinogen
topiramate
bromophen
GluR3
morphine
correlation
SB216
##erpene
231
cinobu
structurally
BMY
Hydrox
##carnitine
##roxen
vasodil
obesity
##ecifically
extract
Pharmacological
GCS
Sp1
antibodies
SUR2B
occur
HbA1c
polymerases
regard
coding
female
loss
tBuB
##intestinal
dextrometh
Activation
autoreceptor
animals
respiration
relaxation
Cdx2
arachidonyl
JAK2
NR1a
##menidine
nicotinamide
estrone
very
##uccinate
propargyl
triggered
Cyanophenyl
MUC2
glyburide
halogenated
##ometric
##quiterpene
7378
DFMO
Depletion
EETs
MCTs
S1P
Western
airway
break
bepridil
cefadrox
cibenzoline
difluoromethylornithine
etomidate
naproxen
rasagiline
rilmenidine
sesquiterpene
##fagin
thapsigarg
isoprenaline
oxymetazoline
apparent
aprindine
arylhydroxylamine
dronedarone
amiodarone
disorders
paraoxon
pronounced
pertussis
GW4064
bromophenacyl
cinobufagin
dextromethorphan
cefadroxil
thapsigargin
02
04
150
265
225
32
3b
349
76
774
Co
Caspase
CRP
CPP
Dv
DRF
Dick
Ez
Et
EGF
FD
FAS
Fisetin
GT
I3A
IMC
INS
Lg
LTA
Lef
Mit
M564
NK
Nov
Nitro
NK1
OSI
Pt
QR2
RT
RN
Str
Tc
TAK
Tarc
U37
Wif
WNT
astemizole
bil
cet
cass
certain
far
focal
fisetin
kit
kip
kynur
lor
late
ml
mag
ros
rif
rim
since
stere
tab
troglitazone
umb
vig
water
xL
##otid
##eat
##yst
##mal
##most
##22
##21
##ik
##iating
##ique
##pri
##pirin
##soc
##toph
##xiol
##gre
##ry
##r5
##kop
##ux
##uxim
##Cs
##CH
##dil
##dens
##GS2
##f1
##X1
##3MG
##MB
##V1
##7A
##ination
##atrin
##onab
anxiol
##itu
##ortal
##aster
##anoid
##anoic
##ice
##ecain
##elzine
##arf
##aramic
##ette
##amid
##amol
##amant
##amole
##ampl
##acet
##acycl
##otting
##omach
almost
##utaramic
aspirin
##tern
condens
##ilical
##oxan
##operoxidase
##antine
##antamine
##ransmit
##eva
##ods
##abil
##abatrin
phorb
stomach
##thel
transamination
adver
adamant
choline
##erebr
##ypes
##yptoph
##ugl
reach
##avir
aggre
oxogl
redox
reducing
spond
##encies
significance
diuretic
carri
cyclase
imp
##othiaz
##ove
neonatal
##oxygenases
##prodil
##azol
##azapril
pla
wee
##timal
modified
##002
acetaminophen
amy
PDE7
disulfide
pyrrol
acetyltransferase
PGs
metabolic
able
above
sugges
##ploy
methys
##ofluor
##ofuran
enhance
enhancer
cyclooxygenases
quinones
phenelzine
dipyrid
corp
included
##ardi
prevents
obvious
hydroxysteroid
lipoprotein
##overed
##ergide
Phosph
histological
##ophore
1250
##inson
##rophy
##rophil
appropri
involve
difference
mTORC1
##benzyl
chemot
consumption
neurop
benzox
cancers
property
stem
##nitude
##bitux
##ampicin
##fenprodil
protective
TSC2
identification
BRN
##ultaneous
provided
captop
activators
carcinogenesis
PTGS2
ASK
##buterol
alpha2B
open
galantamine
##monary
ligands
equal
equival
micromolar
possibility
esterase
subtypes
##lasts
employ
converts
SGK1
myeloperoxidase
preferentially
neurotransmit
remained
##toms
experimental
implicated
initiating
extracts
performed
Dkks
##aleimide
rescu
rescue
steps
variant
##operamide
phthalimide
hypertens
hypertrophy
Erbitux
substance
myristoyl
Epidermal
maxim
particularly
MPH
coincide
electroc
KATI
Trio
nonselective
ribonucle
restored
neutrophil
precursors
formerly
symptoms
NSAIDs
Notch
typical
anthocy
Parkinson
VMAT2
bleomycin
cilazapril
gastrointestinal
pulmonary
xenog
exchanger
microsomes
monocarboxylates
Glutamic
temporally
frequency
simultaneous
coupled
17053
breakdown
2655
Caspase3
Dvl
Dickkop
Ezrin
FDX1
GTK
Lgr5
Lef1
M564G
RNase
Struct
Tcf1
Tarceva
U373MG
Wif1
WNT6
cetuxim
cassette
kip1
kynurenine
magnitude
rifampicin
rimonab
tabun
umbilical
vigabatrin
anxiolytic
##ecainide
##amples
condensation
phorbol
adverse
adamantyl
##erebral
##yptophan
aggreg
oxoglutaramic
spondins
carriers
methysergide
dipyridamole
appropriate
captopril
employed
neurotransmitter
Dickkopfs
cetuximab
rimonabant
06
4P
58
51
72
88
87
Ach
Br
Bec
Brain
C2
CN
CI
Cre
Cot
Ev
FR
FLA
GI
GMC
Her
Ig
IV
Ile
Ket
LK
LH
LDL
Mec
Mod
N2
O2
OTC
PB
PTP
PEC
Pranlukast
Ro
Rel
SDH
Ter
TES
U93
ber
bound
bodies
barbit
core
call
db
den
dCK
find
filament
hE
his
kil
kinsenoside
mu
mP
maz
mocl
pe
pan
pod
pain
peptid
p70
pitu
rh
roc
rivastigmine
sil
ta
uro
##oh
##eb
##nown
##norm
##ykinin
##BG
##2B
##816
##91
##iand
##ais
##tol
##gd
##g3
##gamma
##ring
##rary
##known
##cycline
##la
##CE
##dra
##dSer
##TR
##wal
##RetSat
##FA
##face
##be
##bB
##STA4
##I166
##635
##LE
##H2
##HS
##75
##77
##inastine
##onment
any
##itized
##asion
##roke
##ering
##eridin
##ala
##alis
##aloid
##ecitabine
##idicin
##ising
##ishes
##arabine
acqu
##osidase
##osarc
##ylline
##epar
##epiand
##lying
proinflammatory
##phob
##ocycline
examples
##omized
##iglinide
##urates
##umour
##terenol
constr
confer
conform
isopro
##oxim
##opent
##odibenz
##odopa
##odauc
recovery
cytidine
##emide
envir
##ogram
stroke
##clonidine
##uded
antagonistic
##endages
oxobutyr
oxais
##ancing
selected
compare
applic
reductases
##ethylclonidine
subc
spir
spiro
##indol
inverse
invasion
shif
producers
butoxy
butein
imidazol
##cholinergic
dehydr
deamination
dealkyl
indol
catechol
##oxycycline
clar
released
ars
arbit
##entiation
betaxolol
pregn
##prot
antih
##obemide
tryptophan
modify
amides
assembly
##tidrug
##hydraz
methyltransferases
pyrimidine
abnorm
##platin
uns
untreated
unknown
monitor
PGES
phentol
allergic
diphen
dipeptide
5048
hyperp
corne
cortical
curve
##regulate
ICI
second
##lorodibenz
mutag
elong
1724
glycol
All
##osyltransferases
113
##achlorodibenz
##aglate
nonyl
noncholinergic
prostanoid
NaHS
##atured
sensitized
PP1
pervir
208
collag
meg
##ophylline
epoxy
epinastine
##versely
adenyl
##ildenafil
glucuronosyltransferases
PKI166
efficiency
pharmacotherapy
##icians
##benzenesulfon
p28
cAsp
##clerosis
neurosteroid
benzo
benzofuran
osteosarc
##orphine
##orphism
responsive
MeCP
competitively
##fenadine
RAGE
erg1
erg3
erbB
protection
dehydroepiand
leukaemia
PPARgamma
CYP1A2
ChAT
##2A1
bisphosphon
phosphodiester
methoxybenzyl
provoked
capecitabine
hemat
toloxat
ratios
##ocysteine
classes
DHSG
score
immunod
immunoglob
propylmethyl
CD3
THLE
##iolabel
##rosterone
fluorouracil
fluoropyrimidine
surface
concluded
LTB
hexameth
hypothesized
alkaloid
equilib
##berine
Expression
##enger
abolishes
possessing
Receptor
delta
constitutively
considered
Ang
adenosyltransferase
Uptake
WAY
actually
ibutil
alcohols
##erpine
appendages
BDNF
Rac1
memantine
ED50
MAT1A
many
##rexpip
requiring
Conversely
cisplatin
slowly
methoxymethyl
designed
steroidal
Pro42A
RNAP
ABCC2
ABCC1
BHMT
fibrin
mGlu2
mGlu3
homologous
organophosphate
metalloproteinase
erythro
End
Enalkiren
nerv
##ocarboxylate
elimination
eliminated
SUR2A
occurs
polymerase
##phosphonofluor
Agents
soluble
GluN1
GluN2B
Acetylcholinesterase
confirmed
myristate
radiolabel
yielding
##piperidin
##662
inactivated
ortho
depleted
trimethylbenzenesulfon
Aldo
excitability
guanidine
mimics
palmitoyltransferase
CGPs
KCN
piperazinyl
dichloro
fenoterol
units
demethylation
intolerance
myocardial
challenge
TRR
burial
focus
1033
clofarabine
quinazoline
immunoreactive
Different
TZD
transgenic
refolding
subfamily
PDE10A
tetrachlorodibenz
hGSTA4
safety
begun
hyperglycemia
DHEAS
favorable
IKr
Monocarboxylate
consequence
allele
DASIs
CPPs
Nitrogen
PtdSer
farnes
##sociation
##amido
##uglone
amygd
pyrrolo
corpuscular
##ardiogram
chemotactic
rescued
electrocardiogram
ribonuclease
xenograf
simultaneously
Creb1
Cotreatment
FLAP
GIST
Her2
LKB1
Mecp2
PTP1B
U937
berberine
barbiturates
called
denatured
hENT1
histidine
maze
moclobemide
peak
peptides
pituitary
rocaglate
urokinase
##816V
##drawal
acquired
isoproterenol
environment
oxobutyrate
oxaisodauc
imidazolidin
dehydratase
dealkylation
arbitrary
monitoring
phentolamine
50481
perviridicin
collagen
cAspAT
neurosteroids
osteosarcoma
dehydroepiandrosterone
bisphosphonates
toloxatone
immunoglobulin
propylmethylphosphonofluor
equilibr
ibutilide
##rexpiprazole
Pro42Ala
radiolabeled
trimethylbenzenesulfonamide
amygdala
propylmethylphosphonofluoridate
1H
2a
264
34
36
48
63
70
80
98
Aur
B2
C1
CT
Col
ChE
Carboxyl
Dup
Direct
D816V
ENT1
GP
GNMT
HR
Hist
HMG
IB
IM
IRF
Ifenprodil
Ki
Kinase
LQ
Lew
MX
Met
MT1
MCF
NOX
Of
Over
Pol
Par
Pyr
Prazosin
Rd
RG
SF
SS
SAR
Trans
TMB
Un
UV
Vitro
WE
With
Wist
aut
bacter
brexpiprazole
cP
cD
cetirizine
citr
dN
dim
dest
dimin
dione
eight
fas
furan
he
hk
il
juglone
larg
lactic
label
pen
psych
rit
ring
rand
risperidone
so
sin
sar
sap
skelet
tra
tear
tumour
ves
yet
##oE
##otion
##oester
##eh
##effec
##ezil
##mM
##med
##238
##44
##90
##ias
##iev
##iety
##pite
##hile
##hyth
##hosphorylation
##set
##sulin
##aem
##ture
##ride
##rhyth
##kappa
##cent
##cyp
##creased
##PQ
##dial
##vage
##wise
##5A
##05
##RH
##N1
##bal
##bens
##KPQ
##HA
##HI
##inicians
##atechin
##onins
##onectin
infer
intrac
ineffec
antin
aniline
##itable
##enyl
##estr
##ored
##orption
##aste
off
##ern
##eral
##alid
##icle
##iception
##retin
##idol
##olmit
##olamb
##ish
##isomerase
##etalol
##inephrine
##oscin
##ylcyp
##epezil
##amoyl
##ote
##lysis
proved
proxim
##ocetirizine
##ociception
##omy
##omide
##ominant
##omipramine
##iglitazone
##ithrom
withdrawal
##agon
suitable
##teolol
##oprol
##istry
##antly
##imast
##odi
##odosin
##odeoxy
##ipit
##abetalol
phox
cyste
##unolol
##ogue
orig
##romine
onset
star
stabil
##tagogue
Insulin
Increased
phospholamb
potass
potencies
##endoplasmic
dephosphorylation
decane
deceased
##ances
apoE
##estosterone
##administration
spinal
##etaxolol
dioscin
carteolol
genotype
sharing
cyclobut
imidaz
imbal
hydrophob
hydrolysis
amines
indole
catabol
fact
##oxyflav
##oxyalkyl
clinicians
clomipramine
prepar
preprot
PDGF
contin
contact
glucosidase
glucagon
synthetic
pathogenesis
specificity
specifically
carbamoyl
nucleoside
infected
abund
##plas
unrel
unique
formed
princ
tumors
MAM
month
derivative
phenobarbital
canine
hypother
ACE
tetrahydrocannabinol
##aspiro
secretagogue
sulfone
Alprenolol
##idined
##achykinin
##DCT
calsequ
detox
modeling
##ophil
##ophosph
epinephrine
endothelium
##posed
BPDE
##inseng
promotion
efficient
efficiently
pharmacophore
differentiation
BAAM
p22
NH2
multidrug
accumbens
AM238
Inhibitor
neurokinin
AKt
thiols
thioester
degree
transform
##ynthetic
RAW
systemic
PAO
lesser
gallate
##earch
salvage
##coendoplasmic
hepatotoxicity
nitrobenz
nitrooxyalkyl
proteosomal
CPA
measuring
##ulline
hexyl
equally
damag
##132
RhoA
moiety
adiponectin
precipit
Recent
mimetic
conjunction
considerable
platelets
carbonyl
ACS1
levocetirizine
MT2
donors
donepezil
alterations
deoxycy
fluid
failed
DBDCT
SERCA2
lysosomal
improving
aza
azaspiro
estim
##iazolidined
predominant
neurotoxic
herein
conjugates
fibrosis
kinetic
##gerin
discovered
asthmatic
survival
AEG
batimast
anisomycin
incubated
phthalide
hydrolyze
Phenytoin
solution
progression
resultant
hyperther
topoisomerase
##like
facilitating
colony
pooled
DeltaKPQ
ethers
BV2
Effects
naphthalenyl
levobunolol
levobetaxolol
counteract
EBPbeta
tranylcyp
##obilization
TrkA
oligomerization
MG132
##phenidate
represent
Previously
EGTA
dThyd
alleviate
asymmetric
desensitization
elicited
cascade
introduction
sulfonamides
autoreceptors
rosiglitazone
stereosp
##acyclin
benzoxazinyl
equivalent
maximum
neutrophils
FRD
mPFC
silodosin
application
arsenic
unsaturated
##orphisms
hexamethoxyflav
Aurora
ChEI
Carboxylesterases
GPx
Histamine
IRF3
Lewis
MXF
NOX4
Overall
Pyrrol
RGM
WEHI
Wistar
cDNA
citrulline
dNTP
dimeth
diminished
hkor
randomized
sarcoendoplasmic
saponins
skeletal
##kappaB
ineffective
antinociception
##estrin
##alidomide
##olmitriptan
proximal
##oprolol
phospholamban
potassium
imbalance
hydrophobic
preprotachykinin
unrelated
princip
hypothermia
calsequestrin
AM2389
thioesters
deoxycytidine
SERCA2a
batimastat
tranylcypromine
hexamethoxyflavone
1O
250
238
2J2
311
4M
400
52
5901
74
Au
AX
ADH
APP
Asp
Abeta
BG
Cal
Cap
COS
DSS
ErbB2
Fe
Fer
FCE
GM
GJ
Gen
HP
Human
HIV
Hamster
HDL
IU
IJ
K1
Le
LU
Mn
MC
Mic
Myd
NL
New
NPs
Nateg
NTR
Ov
Ob
OH
PM
Pin
PSI
PRO
Re
RB
RET
Repress
Syn
SNA
Sup
Some
SMO
TI
Ten
TSA
TXM
TAS
Troglitazone
TVP
Vand
YC
Zom
ben
bro
bel
bow
cov
cand
canth
cross
dith
div
dab
epro
fin
five
flow
gel
gem
holding
if
junction
kB
latter
mot
mell
mast
nan
om
ok
oper
pT
pK
p16
peptidyl
p18
pSer
p75
rend
rain
rough
rational
rings
she
sot
sily
six
soy
tro
treat
ul
uter
urin
van
vec
vary
view
way
will
zeb
##zosin
##ysis
##yroid
##marin
##mount
##4002
##82
##8N
##8W
##ioc
##iates
##pers
##phetamine
##h1
##hion
##hiev
##sin
##saz
##sartan
##aic
##testosterone
##xt
##xat
##gers
##rg
##ridine
##citabine
##lometh
##uff
##uzosin
##P70
##101
##52
##03
##AF
##Arg
##fusion
##filament
##fuzosin
##bi
##bow
##bip
##blasts
##SH
##OA
##32
##365
##D00
##IC
##69
##763
##Zen
##jug
##ined
##inil
##initor
##atinase
##onenal
##onoside
##ontal
##hel
##itul
##itus
##itative
##enil
##enesis
##enoic
##orol
##asic
##asts
##asome
##roy
##rofen
theophylline
##tile
##anib
##ales
##iction
##eca
##elecoxib
##idop
##idoxim
##isent
##isation
##aric
##artis
##arrhyth
##eters
##etanib
achiev
##uction
##osed
##ostimul
##osatri
##oselective
##osuccinate
##ylgl
##ulated
##ults
thyroid
##eperoxidase
##amil
##ameters
##acity
##acsin
proposed
##ocatechin
##stand
##duced
examines
exerted
##omen
##omic
##igall
##ural
##uronic
##urbip
alfuzosin
##umat
##umaz
conduc
##iver
##ively
##ilt
isatin
isomerase
##oxzolamide
##ifest
##idemic
##antel
incretin
##odyn
##odoxin
recap
reserpine
##abidop
cyp2
##eminal
##ogens
##oglyc
##ogether
##ogonoside
##roma
##romes
effector
stat
##ticasone
##ynonenal
##raine
##rafen
##raZen
##yptamine
##tagonists
who
reup
##yryl
##yrisperidone
decitabine
decline
oxad
##ichostatin
##ancy
##ancer
##tryptamine
composed
appl
##athic
bearing
##adaic
alpha2A
##indan
##aptan
dilev
##hydrolase
genistin
should
102
101
1069
deacet
##struction
hydrosul
medial
next
clinic
aryl
##progest
PDTC
antiprogest
regulates
plants
coord
coadministration
hydroxyrisperidone
glucuronic
showing
adrenodoxin
synthes
ammon
amrinone
HT4
NFkappaB
##andamide
dissociation
dispers
upregulated
methylene
acetyltransferases
acetylcarnitine
PGJ2
metabolizes
metabolised
aminoindan
parameters
methazol
prel
##examic
##arbamate
oxidize
positively
phenytoin
potentially
hypolip
ICS2
ICAM
includes
objective
obidoxim
obstruction
inflammasome
NOHA
insuff
secretases
##everthel
eluc
intra
##afinil
##ukotriene
cyclinB1
17A
novo
Thalidomide
sulfur
sulfasal
repress
15d
158N
arginases
5HT
Phillyrin
nonsteroid
NaV1
prolyl
association
histone
##oural
PP2A
20S
epoxygenase
epigall
ethoxzolamide
dihydrotestosterone
plasmatic
marine
additional
##position
BPO
##oprost
chloramine
chlorethylclonidine
##RP3
BAL
##5418
cleavages
chemotherap
chemistry
insulinotropic
240
AM63
translation
lipids
point
neurofilament
benzyl
osteocl
thiophen
understand
membran
preventing
##fenac
##sequent
RAD00
flecainide
flurbip
flumaz
##eficiency
PAG
PAM
PAI
PAL
iron
##relsa
immobilization
leukocytes
UGT2A1
1A2
##eicosatri
##930
glutathioneperoxidase
E217
Character
Chronic
frontal
males
malign
BRAF
2739
capsaz
capacity
seen
carcinogens
DHT
HSF1
HSP70
pancreas
alpha2C
built
salmet
normally
protease
JNK1
options
characteristic
mineral
surmount
##olipoprotein
APB
APX
##brisent
NADH
PSM
beclometh
terazosin
modulating
1B1
##veolar
adipocytes
deficiency
HT29
UGT1A7
UGT1A10
bromfenac
dele
partly
market
0591
Antagonists
CHS
LY5418
raising
triggers
trigeminal
macrophages
CRH
MTCs
BRL15
fluticasone
dihydropyridazin
manifest
transiently
particip
Conjug
Platelet
explore
##imerization
35mM
TPH
##escein
incorporation
Therefore
preferential
available
hormones
putative
singlet
experiment
experiments
cyanate
implicating
conjugated
ATF
DM8W
Fluorescein
fibroblasts
##glucose
initiated
Specifically
symmetric
##C90
polypeptide
variety
Felbamate
doxazosin
##294002
hydrolyzes
Again
Erk1
progressive
substances
allergically
Acetylgl
codified
females
losartan
tBid
mimicked
appeared
64662
##redoxin
coincided
scaffolds
Effect
SB365
##rafish
interference
demethylase
intolerant
myocardium
tolerability
MEFs
balancing
tranexamic
##illoid
TrkB
HLM
binds
central
migration
migraine
##ega
enantiomers
catalysts
extensive
behaviors
behavioural
Arabidop
REV
Results
TXA
atheros
augmentation
virus
receiving
indirectly
closest
explores
bioavailable
Afinitor
AstraZen
Carnitine
S6K1
copper
##iskiren
oncology
metastases
ethylmorphine
recommended
SB216763
Hydroxynonenal
Novartis
##asteride
impact
plaque
suggests
Phospholipase
neuropathic
anthocyanin
Structure
aggregation
886
8713
Because
Everolimus
muM
rhArg
##ohist
##bean
spiroxat
shift
pregnancy
antihyp
##hydrazone
hyperpolar
mutagenic
epoxyeicosatri
immunodeficiency
Endothe
KCNH2
xenografts
LQT3
SFO
autoph
destroy
fashion
iloprost
labeling
psychometric
##05930
cysteinyl
original
detoxification
PAOh1
damaged
estimates
predominantly
Pyrrolidine
cDNAs
1O2
23848
311C90
AuF
AXL
ADHD
BGG
Caprelsa
Ferredoxin
FCEO
GJIC
Genistin
IJS
Leukotriene
LUTS
Myd88
NLRP3
Nateglinide
Ovary
Objective
Pin1
PRO1
Repression
SNAP
Suppression
TIMP
TVP101
Vandetanib
Zomig
benign
bowel
cantharidin
dithioc
dabrafen
eprosartan
finasteride
gelatinase
gemcitabine
motor
mellitus
okadaic
pThr
pKB
p185ErbB2
rainbow
roughly
sheep
sotalol
silymarin
soybean
trout
urinary
vanilloid
vector
varying
zebrafish
##itulates
##orolac
##arrhythmic
##ostimulation
recapitulates
cyp2b
reuptake
applied
dilevalol
deacetylase
hydrosulphide
antiprogestational
ammonia
dispersed
methazolamide
hypolipidemic
ICS205930
obidoxime
insufficiently
##evertheless
sulfasalazine
nonsteroidal
epigallocatechin
chemotherapeutic
AM630
osteoclasts
RAD001
flurbiprofen
flumazenil
Characterisation
capsazepine
salmeterol
mineralization
surmountable
##brisentan
beclomethasone
LY541850
BRL15572
Conjugates
Acetylglucos
Arabidopsis
AstraZeneca
spiroxatrine
epoxyeicosatrienoic
TVP1012
dithiocarbamate
dabrafenib
08
22
38
3T3
46
7901
85
86
95
96
AIF
A77
Benz
BCH
Cu
Cor
CNF
Dox
Diclofenac
EDH
EAP
For
G5
H2
HC
High
H12
ID
IGF
Kv
Li
LL
My
Mr
MIF
MIT
No
N49
Nevertheless
Oz
OMT
PFC
Rb
RO
RU
ROR
SA
Sec
Several
T7
Tol
TDC
Two
Uridine
V7
WB
Xy
Zn
Zyr
biphenyl
bron
back
chen
cir
creat
cad
cerebral
chel
dent
duro
dibut
doxycycline
esp
few
firing
feat
famil
gon
ging
gran
gug
gyr
gap
ginseng
hard
hERG
ile
les
lid
lym
lav
loperamide
mug
mess
mak
nam
nav
natri
pmol
ret
rolip
sev
sibut
sildenafil
sclerosis
tonic
trad
tPA
taste
util
warf
women
zRetSat
##oie
##eit
##eas
##zal
##yte
##mide
##mann
##maleimide
##41
##iac
##iotic
##aiac
##tec
##tyl
##tyros
##tub
##tual
##tmann
##x1
##rally
##raction
##ket
##cul
##comp
##lig
##list
##PI
##ving
##AD
##S1
##ODH
##D88
##II
##H1
##HQ
##793
##ino
##inur
##inidin
##atum
##eding
##edative
ana
##itone
##itocl
##enosine
##enbuterol
##esthe
##orr
##orase
##ories
often
##alt
##alin
##icinal
##ions
##ecial
##ibly
##ibrate
##ident
##idated
##etitive
##etrazole
across
##osa
##osides
##entylamino
##ylmaleimide
##ule
##ulations
##ulosa
thiazolidined
##amylase
too
##actor
##aches
##phthal
##phasic
##phinidin
##ocyt
##oconstr
export
##urk
##ithromb
aliskiren
##ume
##umide
##utein
##utaneous
##iled
##iltr
islet
sunit
##teers
##opoie
research
##abase
##ements
##emark
##unetin
##unteers
ones
##henols
states
stand
staining
##iramine
transcarb
adv
chond
##ynitr
##ments
phosphates
reactiv
##yrin
##gulster
microtub
microphthal
apical
apolipoprotein
reductive
before
##ades
##apic
diethyl
diphosphate
butyl
##othal
super
deiod
hydrolase
signals
clotting
clenbuterol
relating
noted
##herin
##ammonium
beta2
antiarrhythmic
##obase
##obalt
##azole
##azoxan
coenzyme
##timization
##optosis
##optote
##00A
acetamido
ampl
##erous
PDE8
discr
disass
disposition
upregulate
stimulates
methylation
pyrrole
acetylation
infar
infiltr
##essary
##ofine
prior
prunetin
review
##arbose
endoplasmic
CYP2H1
investigating
##ectable
dipentylamino
even
evoked
evident
hypothal
VEGFR2
TCPP
analges
desipramine
despite
patch
pattern
biphasic
hydroxytryptamine
1726
ABTS
sulfonic
##actone
##actosyltransferase
##ochondrial
Phase
nonin
sensation
detected
period
percent
colocal
folds
1217
reversibly
10074
PK1
PKG
CYP3A37
##insic
similarly
##rophic
approaches
chloride
chlorophenyl
general
differences
TNFalpha
##benzothiaz
combinations
benzamide
osteop
osteoptote
##orphyrin
underl
underlying
peroxynitr
idazoxan
members
##amphetamine
mediating
protected
606
immortal
PPARalpha
##rocetirizine
##rocyte
##cribed
##126
##12793
Cholesterol
bisindol
##NK1
##icles
seed
DHODH
##100635
##ROD
buffer
hepatobil
ethylene
ethylbenzothiaz
nitrotyros
429
rab7
optimization
fluoride
galactosyltransferase
SCF
SCH
carboxylase
pyrazole
PSS2
PSS1
guaiac
ceramides
##135
defined
HT22
preclinical
interactions
delphinidin
considerably
3A37
LY13
raised
##486
##4864
carbonates
correlate
volume
volunteers
converting
SGC
alteration
BRL35
GR12793
Only
retinol
wortmann
absorption
polymorphisms
MECA
azino
antithromb
antofine
355
CysLTR1
Among
vasoconstr
conjugate
CpGs
ATB
fibroblast
##glumide
initial
completed
knockout
impairs
OBJECTIVES
Dkk1
Dkk2
iodide
polyphenols
depending
component
antibody
cognitive
mixture
##riptyl
albeit
##astrozole
GlcNAcase
benefit
Epi
tubular
##prenavir
##15M
inactivates
depleting
##insenosides
dextrocetirizine
guanyl
CGP
KCNK1
respiratory
relaxations
relationships
predicted
375
bonds
neutral
precursor
HEK293E
Apoptosis
Methylphenidate
balance
foci
intrinsic
##oxatril
dietary
quinazolines
immunoreactivity
oligomeric
centrally
located
terms
##pheniramine
enantioselective
represents
REx
TXB2
atheroma
virtual
recordings
received
bioavailability
Consistent
striatal
striatum
disrupts
excretion
excreted
screening
tBuBQ
tBuBHQ
EtOH
biliary
lorglumide
##otide
weeks
hypertension
N20
kilobase
podocyte
subcutaneous
clarithrom
abnormal
cornea
glycolytic
megabase
adenylyl
hematopoie
WAY100635
tetrachlorodibenzodi
344864
707
HRV
Part
SSAT
Unlike
bacterial
cPLA2
large
sinapic
traff
vesicles
##odeoxych
broad
omega
render
##biopterin
##umatriptan
prelimin
elucidate
malignant
deletion
manifestations
##ohistochemical
468
861
Doxorubicin
EDHF
H1299
Like
LLC
MyD88
Mrp2
MITF
N495K
Ozone
Rb2
ROCK
RU486
RORalpha
SAL
T700A
TDCPP
V715M
Xyzal
Zyrtec
bronch
chenodeoxych
circul
cadherin
dentate
duroquinone
dibutyryl
especial
features
familial
gonad
granulosa
guggulster
gyrus
hardly
ileum
lesions
messenger
namely
navitocl
natriuretic
rolipram
sibutramine
trademark
warfarin
##competitive
##listat
##orasemide
##ocytosis
sunitinib
standard
transcarbamylase
chondrocyte
microtubule
microphthalmia
deiodinase
discrimin
disassembly
infiltration
analgesic
percentage
colocalized
12177A
osteoptotegerin
peroxynitrite
immortalized
bisindolylmaleimide
hepatobiliary
ethylbenzothiazoline
nitrotyrosination
guaiacol
BRL35135
GR127935
wortmannin
antithrombotic
##riptyline
clarithromycin
hematopoietic
tetrachlorodibenzodioxin
circulating
especially
guggulsterone
navitoclax
09
000
1b
210
33
3L
65
7K
77
780
82
92
94
AG
A3
ANP
Amino
AVP
BB
BS
Bam
Bric
Bamb
CV
Cell
Cop
Cmin
Cath
C57
Cross
Celecoxib
DR
DO
Deriv
DOP
Deoxy
During
EN
EX
EH
Even
Etoposide
Fl
FN
FOS
FSH
Go
GL
Gq
Glyc
H3
HD
Hiz
HDA
HCC
Hcy
HAP
I2
Id
INT
Jun
Jap
Kc
Kine
KCC
K18
Kynur
La
LO
Lev
L50
Local
Liver
MV
Min
Molec
Mechanism
MIP
Methionine
Mibefradil
Morr
NB
ND
Nan
Niss
N12
N13
Or
OP
Pan
Pur
Pak
PND
R1
RX
Raf
Rivastigmine
Si
Sa
Sb
Sur
Sodium
Sulf
SF1
SNP
Selective
Silib
Separ
S32
T1
Toc
TTP
Together
U2
VS
W7
W13
Wogonoside
ator
auro
bit
bes
bid
bone
bens
bonding
cit
caly
categ
costimulation
dw
dog
eso
eros
egress
fg
ful
fus
feed
filam
gent
hA
hN
hel
how
haem
ili
jud
kind
let
lov
last
labetalol
mum
matter
pum
pers
plex
pione
rhe
rise
rD2
robu
risk
s1
sst
stor
sem
sir
sex
saline
size
succinate
separ
sedative
te
tw
ten
torasemide
vs
ven
vis
veh
youn
zile
zolmitriptan
##oi
##ohydr
##notic
##nk1
##ze
##yes
##yraz
##monium
##metr
##4G
##474
##io
##iology
##pter
##pran
##poA
##hal
##hom
##hPP
##sper
##says
##aim
##aia
##tes
##tac
##tally
##tane
##taining
##trex
##xig
##gu
##ged
##gly
##gments
##rates
##centration
##culin
##lat
##les
##lic
##lop
##lected
##ubin
##uished
##CG
##delta
##vos
##vastatin
##vaptan
##TNF
##while
##Es
##58
##5I
##553
##RR
##GA
##GR
##GBG
##fus
##fold
##fron
##factor
##S6
##UT
##UCT
##3I
##36
##354
##3beta
##3T3
##ION
##7Y
##726
##inally
##athe
##atonin
##atadine
##oning
##ontin
##onocl
##hex
##heal
intake
inhal
##edg
##edating
##edull
anter
##enes
##enone
##orus
##oroid
##astere
##rotic
##rozole
##eryl
##erts
##eride
##erazide
##anyl
##anked
##anwhile
##alamine
##alently
##icochemical
##iones
##ecuted
##rep
##repression
##retic
##idopa
##olone
##ises
##isul
##isuride
##arian
##etom
acarbose
##osomes
##osensitivity
##yls
##yltransferase
##inguished
thir
##epir
##ephed
##amates
totally
##acental
##acheal
##otrans
proap
##phage
##phocytes
##stained
exp
examine
exerts
executed
exisul
##omit
##omim
##omann
##omolar
##ombinant
##omedull
##igenesis
##ura
##umarin
##umycin
##fficient
##ute
##uton
##ivastine
isoenzyme
isamol
inductive
sustained
sufficient
##teen
##ifies
##iflu
##iform
##opiaz
##optimal
##oporphyrin
##isted
incidence
##imepir
##odend
##odimerization
##ipiz
##iproc
##emase
##emmal
eng
enter
##unted
##ogous
strain
stability
stained
##irection
##irubin
transrepression
choroid
##ynyl
##rahep
##raquinone
##cloz
##udalis
antagonize
phosphomann
attem
attac
white
##izoma
##izures
refer
reTNF
gland
glimepir
glipiz
##gulin
##trum
microv
blot
blad
blind
blotting
blunted
##athomim
suboptimal
alpha3beta
diastere
##hydrogu
share
shoots
cyclopent
cyclopiaz
impl
##porum
##ported
##rolifer
supple
respect
neither
nearly
##ensor
##ensus
##oxykinase
clog
close
claim
relation
cytoch
betaine
beta1A
beta4G
pretreated
prefron
##ferior
antiser
antiplas
##obility
agonism
##azin
contains
placental
speculated
spectrum
concomit
trichostatin
triflu
cofactor
##allel
adrenomedull
##optotic
amylase
amphetamine
ambrisentan
ammonium
HT2A
PDE9
PDE11
stimulatory
methylated
methylanth
methylpiperidin
CA3
pyridin
pyrene
pyridazin
carbohydr
carbidopa
carboxykinase
nuclei
nucleotid
acetylsper
infusion
##rosporum
##otheli
paras
parallel
unsp
##lyceride
method
##aminidase
##ysiology
caudalis
tumorigenesis
interven
indicative
monocytes
oxidizes
cyclohydrolase
CYP2A
##osinophil
quinidine
allodyn
potentiates
everolimus
mitiglinide
presently
prescribed
ACh
##atins
tetrahydrobiopterin
oblig
acceptor
inserted
secreted
secretes
hydroxyimin
Thymidine
sulfamates
repl
repeat
Ala
AlCl
patient
118
controls
##idins
##hydramine
GAL
Phosphorylation
validated
valeryl
nitrate
strateg
reductions
aflat
##yclonal
perfus
20726
##1B2
125
1229
causing
endothelin
##tinol
dihydroor
dihydropter
100mg
plasmal
glucuronosyltransferase
##posure
promise
nordi
chlorpheniramine
##erologous
generates
generally
##amicin
lowered
betamethasone
chemically
chemotherapy
chemosensitivity
consensus
Inhibitors
priming
DEGBG
complexes
pools
neuroinflammatory
extrahep
thiored
##oglucose
proliferating
dosages
Meanwhile
sterol
importance
median
transfection
##entification
flanked
protoporphyrin
irrad
dexmed
##CLC
leukotri
PPARs
PPARdelta
observ
ovine
ovarian
cardiomy
TSC1
Choline
Prexig
aldehyd
##acetic
examining
##umarate
BRCA2
bisoprolol
##ropoi
##ulture
capsa
coumarins
purine
segments
seizures
##ocytic
necessary
##oyltransferase
##1002
physicochemical
ASPA
scav
##butaline
Administration
##coumarin
ARB
AREs
nitrop
nitrogen
##tanoyltransferase
rab5A
propion
degrade
CPBG
melatonin
biosynthetic
biosensor
minocycline
##formoterol
phosphoenol
aspartoac
LTR
##pyruvate
551
NR2C
NR2A
PSMA
terfenadine
Exposure
ionone
ionotropic
Rhizoma
adipogenesis
adipocyte
assessment
attenuating
35428
culture
distinguished
##pocetine
cystolic
cortisone
possesses
Recombinant
delayed
delays
mimosine
##osteric
independently
CHDH
LY294002
##thioglucose
triglyceride
carbonate
epithelia
adenosylhom
encoded
levodopa
##orbed
arteries
PKCI
mammals
MTRR
octanoyltransferase
4021
NSCLC
days
failing
##lings
myeloid
kidneys
236
Gly553
SERCA
heterologous
manumycin
maintaining
anticancer
antiprolifer
absorbed
Concentration
MEG
mesalamine
mesotheli
palinur
BT474
Protein
RNAs
Trx
##490
##glycine
##MCs
preference
ABCC3
neurotrophic
Amrinone
Am80
Amprenavir
AII
BH4
fibers
heregulin
##methylene
##methylxanthine
splice
oligodend
WIN354
AT1A
Clinical
Cloning
COT
Subsequent
homocysteine
homodimerization
racemase
##ecificity
organic
organophosph
leucyl
periphery
erythroid
erythropoi
KAD
Nox1
Stat
Stable
Statins
dysregulation
acutely
arrestin
Assays
vinpocetine
##2949
##venous
procyan
##operazine
hydrolyzed
DLD
Phenols
Phenobarbital
hyperactivity
elements
Galanin
healing
radiation
tuberous
orthologous
facilitates
Aldose
Aldosterone
trifluoromethylcoumarin
palmitoylcarnitine
0066
DeltahPP
naltrex
postpran
acrivastine
##erglycaemic
HSD11B2
piperazin
predict
dichlorvos
isobutylmethylxanthine
MRP2
MRP1
fencloz
nonsedating
restoration
interferon
tolerated
tolerance
arachidonate
challenging
441
ApoA
DPD
DPH
MKK
SLC
##icking
prolonged
NSAID
Cycloxygenase
Cyclopent
GTPCH
PCNA
TZDs
locus
prodrugs
transgenes
subfraction
extension
EGCG
augment
dTGR
asymmetr
recorded
closing
desensitizing
electron
clearance
alkylation
6976
After
Astrocytes
Carvedilol
LC3
oncoprotein
substituent
quantity
quantitative
ethylmaleimide
injections
recommendations
SB21636
Hydroxy
vasodilation
vasodilating
propargylglycine
airways
EtOA
Mitiglinide
bilirubin
loratadine
##ikia
week
hypertensive
582949
AchE
Ketorolac
LHRH
Model
Modafinil
Terfenadine
Terbutaline
p70S6
take
conformations
conformational
spiralis
spironocl
catecholamine
diphenidol
diphenhydramine
elongation
elongating
nerves
nervous
farnesoid
farnesyltransferase
immunoglobulins
equilibria
equilibrative
Polyclonal
Transport
furanopyrimidine
head
ritanserin
intracerebral
stabilization
imidazoline
catabolized
prepared
continue
carbamoylmethylene
abundant
months
transformation
nitrobenzo
precipitate
hyperthermia
representative
stereospecifically
principal
Aspirin
Calu
HPEC
MC3T3
Microsporum
OHC
Synergistic
covalently
crosslin
nanomolar
operated
uterine
##821002
##527
conducted
oxadiazol
synthesizes
membranous
participation
antihyperglycaemic
hyperpolarizing
Endothelium
autophosphorylation
Second
Tolbutamide
creatinine
lymphocytes
making
severe
##esthetic
diethylgly
reviewed
noninferior
osteopontin
seedlings
##RODUCT
vasoconstriction
guanylhydrazone
trafficking
Likewise
chenodeoxycholic
3LL
651
7KC
AG490
BSEP
Bambuterol
Bricanyl
Bambec
Cells
Coptis
DOI
Derivatives
DOPA
Deoxyglucose
EX527
EHNA
FNTA
GLUT
Hizikia
HAPI
Identification
INTRODUCT
Japan
Kcnk1
Kinetic
Kynurenic
Levodopa
L507Y
Minocycline
Molecular
Mechanisms
Morris
NBF
NDGA
Nissl
N125I
N133I
Orlistat
Panx1
Purified
PND35
RX821002
SiO
SaOS
Sur1
SF1126
Silibinin
Separate
S3226
Tocopherol
U2OS
atorvastatin
aurothioglucose
bitter
besides
bidirection
benserazide
calyculin
categories
dwarf
esophage
erosion
fully
fusiform
filaments
gentamicin
hApoA
help
haemoglobin
iliac
judged
letrozole
lovastatin
mumol
pump
plexus
pioneering
robust
sst2
store
sirtinol
separately
team
twice
vehicle
young
zileuton
##aiaretic
##lopride
inhalation
anterior
##etomidine
##ephedrine
proapoptotic
exisulind
isamoltane
phosphomannose
attemp
attacks
reference
glimepiride
glipizide
bladder
##athomimetic
diastereomers
##hydroguaiaretic
cyclopentyl
cyclopiazonic
implant
claimed
cytochromes
beta1AR
beta4Gal
prefrontal
antisera
antiplasmin
trifluoperazine
adrenomedullin
methylanthraquinone
pyridazinone
carbohydrate
nucleotidase
acetylspermine
infusions
unspecific
obligate
AlCl3
aflatoxin
perfused
207266
plasmalemmal
nordihydroguaiaretic
extrahepatic
thioredoxin
dexmedetomidine
leukotrienes
Prexige
aldehydes
capsaicin
phosphoenolpyruvate
aspartoacylase
adenosylhomocysteine
antiproliferative
mesothelioma
palinurin
oligodendrocytes
WIN35428
organophosphorus
erythropoietin
DeltahPPAR
naltrexone
postprandial
fenclozic
Cyclopentenone
subfractions
asymmetrically
SB216367
EtOAc
p70S6K
spironoclactone
diethylglyoxal
INTRODUCTION
bidirectional
esophageal
fusiforme
1beta
222
3D
343
538
512
62
67
616
7a
7H
97
926
AF
Alex
ADP
AT1
Amit
ADs
B4
B5
B6
BSO
Butein
Cent
Cur
Cav
CD1
Cobalt
Culture
Dos
DDA
Def
Doxycycline
EB
ET
Est
Eth
Eight
Erb
F4
Fol
From
FAD
Finally
Gn
G6
GRK
Gene
GDP
Ginsenosides
H4
HF
Hyp
Hup
HDH
HER
HOP
Is
IT
IMP
Jasp
Jurk
Lp
Lu
Lol
Low
LFA
Labetalol
Mc
MI
Med
Mul
Maz
Nt
N1
NCA
OVA
Oct
OFC
OST
Prom
Pse
PLA
PCO
QS
Ra
Rap
RCA
RXR
RetSat
SN
SI
SV
Sim
Sign
Sper
Saturated
Sildenafil
Sumatriptan
TB
Ta
TE
TA
TN
Tot
Tab
TMP
VK
V65
While
Zolmitriptan
azol
aura
best
cip
cases
cess
cotrans
dar
dir
dend
delet
eug
erad
eze
eosinophil
gr
ginsenoside
hy
hp
hS
hD
harb
hAR
hCT
hither
hedg
iD
ker
licofelone
lack
lisuride
mor
mif
mov
made
mature
mortal
mRetSat
nA
net
nad
ole
oroc
periv
rP
rot
rod
rods
sk
suc
tes
tone
tanoic
uc
vac
vogl
##oat
##oal
##ooxygenase
##oephedrine
##eff
##neal
##zed
##yran
##mun
##midine
##moxetine
##BS
##B3
##BL
##4A
##450
##470
##96
##i1
##iar
##ient
##ires
##put
##pose
##pogen
##hR
##hout
##sk
##sO
##sur
##aec
##to
##tant
##type
##tective
##tosomes
##rit
##ritis
##king
##c2
##cines
##chem
##covery
##lad
##lases
##lect
##laf
##uod
##uenesulfon
##Ca
##ChR
##PK
##PLA
##PTA
##des
##dom
##voac
##wor
##went
##E1
##09
##AsO
##RA
##RSS
##N2
##bic
##boxetine
##OL
##324
##M7
##MECs
##D12
##IS
##juv
##atidine
##atidyl
##ontan
##here
inst
intim
inade
##edi
anirac
anthel
anandamide
anastrozole
##orel
##orib
##oring
##order
##asi
##astic
##asted
##tianine
andcle
##erin
##erated
##eractivity
##anandamide
##anidins
##alop
##aldehyde
##icted
##ionein
##ecan
##elerated
##ibe
##ibose
##reven
##identif
##olenic
##etam
##oste
##osome
##entity
##ylated
##eptin
##amuscular
tomoxetine
##acted
##ached
##oter
##otate
##otyp
promin
progest
prosur
##resveratrol
##ocon
exert
##omoxetine
##igu
##leen
##lement
alveolar
##umatic
##utaryl
const
contex
conven
##rants
##agement
isox
isometric
##oxine
##oxamine
##oxyphenyl
##ydiar
##opir
##opreven
forsk
##istone
##imally
##uss
##odiaz
##ipip
##ipocytes
washout
resorb
##abor
##abend
enoic
enalkiren
##unt
##unc
##thritis
##ogall
signs
stage
##ticle
##ticular
transit
transduction
chap
cholec
chron
##ereb
##cles
##mintics
Int
Induced
##udies
##udoephedrine
phosphorib
proteinase
attr
atRA
atomoxetine
##izatidine
ready
reboxetine
##endothe
##avy
##aved
aggress
syngen
oxantel
kinase1
##trimethyl
complement
microL
microdial
##genomic
##estine
##estrants
##adap
##adipocytes
spleen
##ialylated
##individual
##encing
##apride
##aplad
diff
dioxin
genomic
gentianine
shunt
butynyl
butoxamine
imipramine
##renoceptor
10mg
##othionein
##rols
defer
deendothe
##thern
hydrolases
media
CYP450
aminoglyc
respond
indeno
neoin
neoplas
metoprolol
releas
notably
aripip
article
preadipocytes
regulator
##obenz
##oblasts
##arginine
##ques
##quine
serving
triaz
tracheal
cooper
coeff
hydroxyp
hydroxydiar
glucogall
shows
drastic
##timibe
##ogenetic
modifies
##tractant
##anded
##ander
EPS
downregulate
##keukin
suppressor
throughput
carbacyclin
influx
metabolizing
abrup
parent
##plate
unester
unve
until
uncompetitive
unidentif
having
##lycemic
methach
methods
##aminergic
##portantly
formyl
##ysialylated
MAs
MAC1
interc
interest
intermed
interindividual
interkeukin
indication
monophosph
endopeptidase
CYP27A
CYP2E1
foundation
phenethyl
phenotype
potentiate
event
hypomethyl
hypoglyc
corr
cortic
corneal
##regulating
##lialization
##atinocytes
##axine
accelerated
##ongs
secretase
142
1409
intestine
demonstrating
##unctional
ABT
lipase
lipophil
repa
##ubation
##activators
##sterols
##tening
##tention
##idinone
GAS
nonc
nongenomic
prostacyclin
NaAsO
smok
sensory
caldes
myometr
otherwise
permit
peritone
attention
205
polysialylated
clearly
12h
##okinin
reversal
dihydromor
100635
plasm
##serine
##oprotective
approach
potentials
132
13b
oxyresveratrol
oxysterols
naphtho
mannose
##incubation
BAPTA
##icients
chemoat
chemopreven
cytosine
improve
metallic
metallothionein
AM12
Wnt6
##MAPK
contrasted
contracts
contractile
##clerotic
neuroadap
benzodiaz
osteocal
osteoblasts
extend
thioperamide
thiabend
responsiven
underwent
dosage
peroxidation
newly
##okinetic
identity
stearic
mediators
RANK
RAAS
p38MAPK
##erule
protects
dopaminergic
ylmethyl
immobility
1A1
muscles
##934
presented
TST
TSH
##ERT
Preincubation
##esterone
##eutical
Gli1
CYP2B4
##tism
##tisol
provocation
chloroquine
tolvaptan
toluenesulfon
determining
determinant
purpose
##ibuted
probable
classic
pyrido
pyridoxine
SHP
##oylamino
Acetazolamide
sci
##butamol
AdSS
Adenyl
Adenosine
salts
salbutamol
link
linolenic
##roids
##roidism
immunogenic
immunohistochemical
injured
##rogens
##rostene
##omethylket
minimal
minimally
calculations
DAPI
##brid
analytical
became
##Cl2
module
developmental
normalized
Extracellular
Experim
ionomycin
##iderable
glucocorticoste
define
preceding
mammosp
##ections
biosynthesised
Anti
PUFA
##lastic
LSD
RSD12
ocular
template
supporting
PDE4B
HbF
lysosome
retinal
retinoic
##A424
##otropin
requires
neural
improvements
azepine
cisapride
lumen
slowed
slower
##vival
##tility
steroids
39166
TPO
Attention
fibril
fibrate
fibrates
hormonal
remains
remik
implicate
implications
sequestrants
ATM7
F344
Substituted
raclopride
##glutaryl
catalpol
Pharmacokinetic
Pharmaceutical
peripherally
heterod
Studies
pIRS
steppogen
synaptosomes
palmitic
A1R
CEA424
androgens
antibiotic
abrogates
profiling
HED
hearts
pentetrazole
progressively
region
triacsin
hyperthy
Acetaminophen
confirming
IRS
dynamin
tubulin
tuberin
##ruption
orthosteric
shortening
endometrium
AM404
excitotoxicity
Activity
Activating
guanylate
morpholino
appears
005
003
007
MPTP
MP470
autism
outc
##epristone
electroph
predicting
dichlorobenz
CdCl2
Triacsin
freely
pressures
ribosylated
##mbe
counteracted
DPC
NR5A
TRIF
TRPV1
burst
turnover
##284
intrat
intramuscular
clofibrate
nicotinamides
Differences
2H3
Cyclooxygenase
Notably
saturation
saturating
types
##onucleotide
293284
Imatinib
Importantly
Northern
hGR
begin
electrically
DHEA
alkylated
explored
Betaxolol
Considerable
Discovery
Disorder
Disruption
HGC
Methoxy
Methods
Methanandamide
Neuro
cascades
fasting
localization
substitution
substituents
metastasis
disruption
introduced
sulfonyl
Mitochondrial
Novel
RTI
##ystokinin
##21934
##ternal
stomachs
implying
##othiazines
plaques
##002mbe
Phosphatidyl
neuropeptide
anthocyanidins
Structural
Ketamine
podocytes
tau
construct
constricted
clarified
abnormally
corneas
megalin
adenylosuccinate
hematological
focused
tetrachlorodibenzo
Colo
Colonic
UVB
heavy
##ehog
##aemontan
officinal
##ernaemontan
starting
apoE3
imidazole
continu
carbamoyloxy
abundance
##plasia
transforming
nitrobenzoyl
hyperthermic
dimethocaine
principally
FeSO
Reactivators
RBC
RBL
belongs
candoxatril
divaric
mastocytosis
ultim
coordin
coordination
intravenous
5HT1B
benzyloxyphenyl
understanding
atherosclerosis
atherosclerotic
cyp2b9
cyp2b10
Acetylglucosamine
Acetylglucosaminidase
CuSO
Cortisol
HCN2
ID50
IGFBP
Kv11
ZnSO
ginger
lidocaine
lavage
thiazolidinedione
advant
beta2AR
infarction
hypothalamic
underlie
LY1396
preliminarily
bronchoal
discriminating
C57BL
Flecainide
HDAC1
MVs
Nanog
VSMCs
citalop
dogs
hNET
persisted
rheumatic
tenfold
venlaf
visual
expanded
strains
microvasculature
concomitantly
CYP2A7
replac
strategy
dihydroorotate
dihydropteridine
irradiated
observations
scavenger
propionamide
Stat5
procyanidin
crosslinks
implanted
53857
61603
9268
AF21934
Alexander
Amitriptyline
Central
Curcumin
Cav3
Doses
DDAH
Deficit
Estrogens
ErbB3
F442A
FADS2
GnRH
Hyperactivity
HDHA
ITD
Jaspamide
Jurkat
LolA
McN
Mazindol
Ntp
NCAM
Oct4
Promoter
Pseudoephedrine
QSAR
Rapamycin
RCAN1
SIH
SV40
Sim2
Spermidine
TBK1
TAg
TNBS
Total
Tabernaemontan
TMPRSS
V654A
azoles
ciprostene
cessation
cotransporter
daraplad
directed
dendrit
deleted
euglycemic
eradication
ezetimibe
hybrid
hpf
hSERT
hDAT
harboring
hCTR1
hitherto
hedgehog
iDMECs
keratinocytes
morantel
mifepristone
moving
mortality
nAChR
networ
nadolol
orocaec
perivascular
rota
skin
uc002mbe
vaccines
voglibose
##lecting
##uodenal
##voacamine
##3243
intima
inadequ
aniracetam
anthelmintics
andcleaved
prominent
prosurvival
context
##opiridol
forskolin
resorbing
chaperone
cholecystokinin
phosphoribosyltransferase
attributed
aggressive
syngeneic
##trimethylammonium
complementary
microdialysis
butynyltrimethylammonium
deferens
deendothelialization
aminoglycoside
neointimal
neoplastic
aripiprazole
coefficients
hydroxydiarylamide
glucogallin
abrupt
unesterified
unveiled
unidentified
methacholine
MAC13243
monophosphated
CYP27A1
hypomethylates
lipophilic
smoking
caldesmon
peritoneal
dihydromorin
chemoattractant
chemopreventive
AM1241
neuroadaptive
benzodiazepine
osteocalcin
thiabendazole
responsiveness
RANKL
toluenesulfonylamino
Adenylosuccinate
Experimental
glucocorticosteroids
mammosphere
RSD1235
remikiren
steppogenin
hyperthyroidism
dichlorobenzoylamino
intramuscularly
Phosphatidylserine
divaricata
LY139603
bronchoalveolar
citalopram
venlafaxine
Tabernaemontana
TMPRSS4
darapladib
dendritic
network
orocaecal
024
048
19
1h
1a
1C
1S
1L
193
1C2
2S
3S
357
3rd
49
41
59
56
500
66
601
78
73
700
81
83
8we
826
832
9H
915
AD
Arom
Amin
A2A
AOP
BC
BN
B3
BW
Bid
Bef
Burk
CF
Cus
Chen
Cand
Carb
CCA
Cetr
Comp
Compan
CNS
Cancer
D4
DI
Des
Dre
Doc
Darb
Dual
Density
ET1
Emax
Emb
Ehr
Fav
Five
Flav
FIP1
FFA
